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Chapter 1 
Introduction 
1.1 Background and objectives of barrier functional protein analysis in yeast 
The budding yeast Saccharomyces cerevisiae is a commonly used eukaryotic model organism. 
Eukaryotic genomes are organized into heterochromatin and euchromatin domains. 
Heterochromatin domains have a condensed chromatin structure, which inhibits gene 
expression. Conversely, euchromatin domains maintain relaxed chromatin structure that can 
be accessed by the transcriptional machinery to activate gene expression. In S. cerevisiae 
telomeres, the HM silent mating type loci (HML and HMR) and ribosomal DNA (rDNA) are 
known as transcriptionally silent regions. The following figure illustrated the position of 
silencing regions at the chromatin of yeast nucleus 
 
 
 
Fig. 1.1 Transcriptional silencing regions in Saccharomyces cerevisiae 
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The Sir (Silent Information Regulator) protein complex, consisting of Sir2, Sir3 and Sir4, 
plays a key role in transcriptional repression. The NAD
+
-dependent histone deacetylase Sir2 
modifies the tails of histones H3 and H4 and creates binding sites for Sir3 and Sir4 (Rusche et 
al. 2003). Gene silencing in the rDNA region requires only Sir2, but Sir2, Sir3 and Sir4 are all 
required for silencing of the HMR region, the HML region and the telomeres (Rusche et al. 
2003).  
Boundary elements separate heterochromatin and euchromatin domains. Until recently, two 
distinct models were proposed to explain the mechanism of boundary formation (Sun et al. 
2011). According to the DNA sequence-dependent model, tDNA sequences at the right side of 
the HMR domain (Donze et al. 1999; Donze & Kamakaka 2001, 2002; Oki & Kamakaka 
2005; Dhillon et al. 2009) and STAR (Sub-Telomeric Anti-silencing Regions) sequences near 
the telomeres (Fourel et al. 1999) control the extent of transcriptional silencing. The DNA 
sequence-independent model depends on competition between the Sir2 histone deacetylase 
and the histone acetyltransferase (HAT) complexes, SAS-I, SAGA and NuA4 (Kimura et al. 
2002; Suka et al. 2002; Kimura & Horikoshi 2004). We developed a genome-wide screening 
system to test the ability of Gal4p DNA-binding domain (GBD)-fused proteins to prevent the 
spread of transcriptional silencing. By screening a genome-wide yeast library for proteins 
with barrier function, we identified 55 genes able to restrict silenced chromatin domains from 
spreading and concomitantly repression of neighboring gene (Oki et al. 2004). Here I 
characterized one of these proteins, named Sgf73, which has previously been identified as a 
subunit of the SAGA (Spt-Ada-Gcn5-acetyletransferase) and SLIK complex (Lee and 
Workman, 2007). 
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Table. 1.1 Isolated 55 Barrier Functional Proteins  
Histone 
modification 
SWI/SNF Transcription 
Related 
genes 
Cell cycle Other Unknown 
 
SPT10 
EPL1 
YNG1 
SAS2 
SAS5 
ADA2 
ADA3 
ADA5 
HFI1 
SGF73 
SGF29 
DOT1 
LGE1 
YCR082W 
SNF5 
SNF6 
 
TBP1 
TAF47 
TAF17 
TAF90 
TAF60 
TAF61 
TAF30 
GAL11 
MED2 
MED6 
MED8 
ROX3 
ACE1 
HSF1 
LEU3 
RGT1 
FIO8 
ACA1 
SWI5 
HMRA1 
SPT21 
TFA2 
YBL081W 
YDR223W 
 
SIW14 
CLB1 
MND2 
 
LYS5 
ICY1 
YAP1802 
SEC35 
SWA2 
GDS1 
SFP1 
GIC1 
MRS6 
YDR031W 
 
YBR271W 
YCR076C 
 
 
 
Misregulation of transcription results in the development of multiple types of cancers and 
neurological diseases in humans. Packing of DNA into chromatin has a prefound impact on 
gene expression. Changes in chromatin structure influence gene expression. Gene expression 
is regulated by chromatin structure. Genes those are located in the euchromatin region are 
transcriptionally active. Chromatin boundary can prevent transcriptionally repressed 
heterochromatin domain from spreading into active euchromatin region. The following model 
will help to clarify the gene expression mechanism and chromatin structure in eukaryotic cell.  
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Fig. 1.2 Gene expression regulation mechanism by chromatin structure 
 
Nucleosomes are composed of 150 bp DNA which wraps around a core histone octamer . 
The Histone core is subjected to various post-translational modifications including acetylation, 
methylation, ubiquitination, phosphorylation, sumoylation. Acetylation and ubiquitination 
play a key role in gene regulation. Acetylation of histones is associated with loose chromatin 
structure that allows transcriptional machinery to access genomic loci for activation, whereas 
histone ubiquitination is linked to both gene activation and repression (Brownell et al. 1996; 
Weake & Workman 2008; Koutelou et al. 2010). SAGA is a multi-protein chromatin 
modifying complex that is highly conserved from yeast to humans (Lee and workman, 2007). 
The SAGA complex, which is composed of approximately 20 protein subunits with distinct 
structural and functional modules, is involved in transcriptional activation (Brand et al. 1999; 
Wu et al. 2004; Baker & Grant 2007). One of these SAGA modules contains the 
acetyltransferase Gcn5 together with Ada2, Ada3 and Sgf29. This association activates Gcn5 
to acetylate multiple lysine residues on nucleosomal histone H3 and plays an important role in 
HAT activity in vivo (Grant et al. 1999; Balasubramanian et al. 2002; Bian et al. 2011; Weake 
nucleus
Chromosome
CHROMATIN
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et al. 2011). Conversely, the yeast deubiquitinase Ubp8 is activated, together with the 
protein subunits Sgf11, Sus1 and Sgf73, to catalyze histone H2B deubiquitination (Henry et al. 
2003; Ingvarsdottir et al. 2005; Lee et al. 2005; Kohler et al. 2008; Zhang et al. 2008; Zhao et 
al. 2008; Lee et al. 2009; Kohler et al. 2010; Samara et al. 2010; Lang et al. 2011; Weake et 
al. 2011). SAGA-mediated deubiquitination of ubiquitinated H2B destabilizes promoter 
nucleosomes. As a result, recruitment of RNA polymerase II to weak promoters is enhanced, 
facilitating the binding of factors important for transcription elongation (Weake & Workman 
2012).  
In addition to these enzymatic modules, SAGA contains Tra1, a transcription 
activator-binding protein, and several Spt proteins (Lee et al. 2011). Tra1 interacts with 
transcription activators and recruits SAGA to promoters (Brown et al. 2001; Helmlinger et al. 
2011; Weake et al. 2011), and Spt3 and Spt8 directly interact with components of the general 
transcription machinery, such as TBP (Sterner et al. 1999; Larschan & Winston 2001; 
Laprade et al. 2007; Mohibullah & Hahn 2008; Weake et al. 2011). Three core components, 
Spt7, Spt20 and Ada1, are required for the structural integrity of the SAGA complex (Wu & 
Winston 2002). Gcn5 and Ubp8 are the catalytic proteins of SAGA, while the rest of the 
components are important facilitators of Upb8 or Gcn5 catalytic activity. The HAT Gcn5 and 
its associated complexes regulate the transcription of a variety of genes in yeast (Zhang et al. 
2008). Four Gcn5 complexes have been identified thus far: SAGA, SLIK (SALSA), ADA and 
HAT-A2 (Lee & Workman 2007). The SAGA and SLIK complexes are comprised of 
identical components with one exception: the SLIK complex contains a C-terminal truncated 
form of Spt7 and Rtg2 instead of Spt8 (Pray-Grant et al. 2002; Spedale et al. 2010). Rtg2, a 
unique component of SLIK, is important for the integrity and normal fractionation of the 
SLIK complex (Pray-Grant et al. 2002). Sgf73 appears to play a crucial role in anchoring the 
deubiquitination module to both SAGA and SLIK (Kohler et al. 2008; Lee et al. 2009; Lai et 
al. 2010; Samara et al. 2010). Here, we explore a new function of Sgf73 in the establishment 
of transcriptional silencing boundaries and determine the influence of the HAT activity of 
Gcn5. 
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1.2 Background and prospects of erucic acid content in rape seed 
Brassica oilseed have gained widespread acceptance worldwide largely because of major 
improvements in the oil and meal quality. Brassica species are now the second largest oilseed 
crop after soybean in the world oilseed production and became third in position on yield 
during the last two decades (Wang 2004, Raymer 2002). World vegetable oil markets are 
highly competitive requiring a steady improvement in oil quality to increase market prospects. 
The objectives of modifying oil quality is to develop oils with enhanced nutritional and 
functional properties and which require if possible no further processing for specific end-use 
markets. Brassica oils represent a vast renewable resource of highly reduced carbon. The 
market for rapeseed oil is primarily for human consumption, but also for a range of non-edible 
applications, such as lubricants, plasticizers and detergent ingredients (Craig and Millan 1995). 
In traditional Brassica oilseeds, the occurrence of the two components 22:1 and glucosinolates 
are considered as anti-nutritional factors for both of the human and animals consumption, 
therefore their contents were minimized by breeding and finally released Canola or ‘00’ 
(Przybylski and Mag 2002). In technical point of view, oil with higher amount of 
polyunsaturated fatty acids has low oxidative stability, is not suitable for frying and deep 
frying purposes. Therefore, Rakow (2004) has been attempted to breed oilseed rape cultivars 
with low linolenic acid content by mutation. Chemically induced mutants have been 
successfully obtained which raise oleic acid contents up to 80%. Crossing with other high 
oleic acid genotypes and continued selection for a high oleic acid in the seed oil, known as 
high oleic acid  content led to the development of genotypes that had 86% oleic acid in the 
seed oil, known as high oleic acid rapeseed; HOAR (Schierholt et al. 2001). Sasongko and 
Möllers (2005) combined the genes for high erucic acid with those for high oleic acid in order 
to increase the pool of oleoyl-CoA available for fatty acid elongation. In comparison to the 
high erucic acid parental line, they found reduced contents of polyunsaturated and saturated 
fatty acid and increased contents of oleic acid and eicosenoic acid. However, no significant 
change in the erucic acid content was observed. This material was named as High Erucic and 
Low Polyunsaturated fatty acid (HELP).  
The development of seed oils bearing a high percentage of erucic acid for industrial 
applications is a subject of research (Kott et al. 1996) because they are very excellent 
renewable raw materials used in plastic film manufacture, in the synthesis of nylon 13 and in 
the lubricant and emollient industries. Attempts are being made by conventional breeding to 
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increase the erucic acid content. This has so far resulted in breeding lines with up to 60% 
erucic and eicosenoic acid. These fatty acids are found in the sn-1 and sn-3 position of the 
triacylglycerols but are excluded from the sn-2 position. This sn-2 exclusion limits the erucic 
acid together with the eicosenoic acid content to a total of 66% and prevents the synthesis of 
trierucin (katavic et al. 2001). To overcome this theoretical limit, combined efforts in plant 
breeding and genetic engineering have been undertaken. The gene of an erucoyl-CoA 
preferring sn-2 acyltransferase (LPAAT) from meadowfoam (Limnanthes douglasii L.) has 
been successfully cloned and over expressed in rapeseed (Brough et al. 1996, Friedt). 
However, the overall proportions of 22:1 in the seed oil did not increase. In a next step 
interest focussed on the fatty acid elongation mechanism from oleic acid to eicosenoic acid 
and then to erucic acid. This elongation is the result of 2 cycles of a four-step mechansim, in 
which 18:1-CoA are used as substrates. The first step, the initial condensation reaction of 
these fatty acids with malonyl-CoA is catalysed by the β-ketoacyl-CoA-synthase (KCS). It is 
believed that this initial condensation reaction of these fatty acids with malonyl-CoA is 
catalysed by the B-ketoacyl-CoA-synthase (KCS). It is believed that this initial reaction the 
rate limiting step (Cassagne et al. 1994). The fae-gene encoding the β-ketoacyl-CoA-synthase 
has been cloned from a range of plant species and has been over-expressed under control 
under control of a seed specific promoter in transgenic HEAR. The results of these 
experiments showed that there was only a minor increase in erucic acid content (Han et al. 
2001). Even in combination with the expression of the Limnanthes spp. LPAAT no substantial 
increase in the erucic acid content has been found (Han et al. 2001). This indicates that there 
are other bottlenecks in the pathway, such as the pool of oleic acid available for elongation to 
eicosenoic and erucic acid, or the activities of the other three enzymes of the elongase 
complex, that limit erucic acid synthesis. To observe the limitations of erucic acid synthesis in 
seed oil, transgenic and nontransgenic approach are combined in this study and experiment 
was performed with doubled haploid (DH) population which comes from the cross between 
transgenic parent (1 transgene copy Ld-LPAAT-Bn/fae1) and non-transgenic parent (1 major 
and 2-3 minor genes for low polyunsaturated fatty acid content). In the present study, 90 DH 
lines come from F1 plant were analyzed and evaluate the variation, heritability for different 
phenolgical traits such as days to flowering and maturity and quality traits like oil content, 
protein content, different fatty acid content. Here I also study the inheritance of erucic acid 
content in the segregating transgenic DH population. 
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Chapter 2 
Characterization of Sgf73 for heterochromatin boundary 
formation 
2.1 Introduction 
SAGA is a 1.8 MDa dynamic multi-protein complex that can acetylate and deubiquitinate 
histones ( Grant et al, 1997; Daniel and Grant et al, 2007 and Bhaumik, 2011). Non-essential 
components of yeast like Gcn5, Ada1, Ada2, Ada3, Spt3, Spt7, Spt8, Spt20, Sgf11, Sgf29, 
Sgf73, Ubp8 and Sus1 present into SAGA complex, SAGA also contains Tra1, Taf5, Taf6, 
Taf9, Taf10, and Taf12 which are essential for yeast (Lee et al, 2000). In yeast one of the most 
well characterized process in regulating chromatin structure is the post-translational 
modification of histones. The SAGA complex provides a paradigm for multi-subunit histone 
modifying complex. Histone modifications, such as acetylation and ubiquitination, play vital 
role in facilitating a number of cellular events, including gene expression. Our group 
previously developed a genome-wide screening system to examine the boundary formation 
ability of GAL4 DNA binding domain (GBD)-fused proteins from S. cerevisiae; this 
technique was used to isolate 55 boundary proteins from approximately 6000 genes (Oki et al. 
2004). Sgf73 is belongs to the 55 boundary related proteins. This study describes the 
characterization of Sgf73, which has previously been identified as a component of the SAGA 
(Spt-Ada-Gcn5-acetyltransferas) and SLIK (SAGA - like) complex and is conserved between 
yeast and human which support its importance to transcriptional regulation. Primary sequence 
analysis illustrates that Sgf73 contains two zinc finger motifs, one is located in the N-terminal 
(ZnF1) and another one in the center of Sgf73 protein (ZnF2) (Lai et al. 2010). The Zinc 
finger domain 1 consists of amino acids 70–104 and zinc finger domain 2 containing amino 
acids 227–272 of Sgf73 (Fig. 2.1) (Lai et al. 2010). The N-terminal ZnF1 motif of Sgf73, play 
an important role to anchor the deubiquitination module consists of Ubp8, Sus1 and Sgf11 to 
SAGA and SLIK (Kohler et al. 2008; Lee et al. 2009; Lai et al. 2010; Samara et al. 2010). 
Whereas, another Zinc finger domain (ZnF2) is important for nucleosome binding and 
important for chromatin interactions (Bonnet et al. 2010). The following figure showing the 
position of different domains within Sgf73 protein. 
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Fig. 2.1 Position of know domain within Sgf73 
 
In this study, domain analysis of Sgf73 was performed to indentify the minimum region that 
play crucial role to mediate barrier function. Here I determined relevant proteins those could 
be associated with Sgf73 and are necessary for its boundary function. Furthermore, disruption 
strain (different SAGA subunits were deleted) mating analysis was carried out to identify the 
proteins those are necessary for Sgf73 boundary. I also evaluate boundary activity of the hat 
mutant to determine whether GCN5 HAT activity is necessary or not. Finally this study 
suggests that histone acetylation activity is necessary for Sgf73 boundary function and SAGA 
and SLIK both complex can bind into our minimum region to mediate boundary activity 
 
2.2 Materials and Methods 
2.2.1 Materials: 
 Yeast strains: All yeast strains used in this study are listed in table 2.1. 
 Plasmids: All plasmids used in this study are listed in table 2.2 
 Primer pairs: Primer pairs those are used for domain analysis are listed in table 2.3. 
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Table. 2.1 Yeast strains  
Strain Genotype Source 
ROY2041 
MAT @ ADE2 lys2Δ his3-11 leu2-5,112 trp1-1 hmrΔ::bgl-bclΔ ura3-1::HMRΔI::URA3 (Oki et al., 
2004) 
ROY2042 
MAT@ ADE2 lys2Δ his3-11 leu2-5,112 trp1-1 hmrΔ::bgl-bclΔ  ura3-1::HMRΔI+4xGal4 bs 
at mat a2(ECONI)::URA3 
(Oki et al., 
2004) 
JRY19a 
MATa ADE2 LYS2 his4-519 leu2-3,112 trp1 ura3-52 (Donze et al., 
1999) 
FUY594 
MAT@ ADE2   lys2Δ  trp1-1  his3-11  hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at 
mat a2(ECONI)::URA3 spt3Δ::KanMX4 
This study 
FUY596 
MAT@ ADE2   lys2Δ  trp1-1  his3-11  hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at 
mat a2(ECONI)::URA3 spt8Δ::KanMX4 
This study 
ROY2120 
MAT@ ADE2    lys2Δ  trp1-1  his3-11  hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at 
mat a2(ECONI)::URA3 gcn5Δ::kanMX 
This study 
ROY2220 
MAT@ ADE2 lys2Δ  trp1-1  his3-11  hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at mat 
a2(ECONI)::URA3 ada2Δ::kanMX  
This study 
ROY2240 
MAT@ ADE2 lys2Δ  trp1-1  his3-11  hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at mat 
a2(ECONI)::URA3 ada3Δ::kanMX  
This study 
FUY392 
MAT@ ADE2 lys2Δ  trp1-1  his3-11  hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at mat 
a2(ECONI)::URA3 pep4Δ::kanMX 
This study 
FUY614 
MATa ADE2  lys2Δ  his3-11  leu2-5,112 hmrΔ::bgl-bclΔ ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-3×flag::TRP1  
This study 
FUY615 
MATa ADE2  lys2Δ  his3-11  leu2-5,112 hmrΔ::bgl-bclΔ ura3-1  sgf73Δ::hphMX 
trp1-1::GBD-SGF73-3×flag::TRP1 
This study 
FUY616 
MATa ADE2  lys2Δ  his3-11  leu2-5,112 hmrΔ::bgl-bclΔ ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-SGF73(Δ373-402 aa)-3×flag::TRP1 
This study 
FUY617 
MATa ADE2  lys2Δ  his3-11  leu2-5,112 hmrΔ::bgl-bclΔ ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-SGF73(373-402 aa)-3×flag::TRP1 
This study 
FUY592 
MAT@ ADE2    lys2Δ  trp1-1  his3-11  hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at 
mat a2(ECONI)::URA3 ahc1Δ::KanMX 
This study 
FUY586 
MAT@ ADE2 lys2Δ trp1-1 his3-11 hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at mat 
a2(ECONI)::URA3 ubp8Δ::kanMX 
This study 
FUY131 
MAT@ ADE2    lys2Δ  trp1-1  his3-11  hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at 
mat a2(ECONI)::URA3 sgf73Δ::KanMX 
This study 
FUY364 
MAT@ ADE2   lys2Δ  trp1-1  his3-11  hmrΔ::bgl-bclΔ ura3-1::HMRΔI+4×Gal4bs  at 
mat a2(ECONI)::URA3 sgf29Δ::kanMX 
This study 
FUY905 
MATa ADE2  lys2Δ  his3-11 ura3-1 sgf73Δ::hphMX trp1-1::GBD-3×flag::TRP1 
leu2-5,112::G196-Spt7::LEU2 
This study 
FUY906 
MATa ADE2  lys2Δ  his3-11 ura3-1 sgf73Δ::hphMX trp1-1::GBD-SGF73-3×flag::TRP1 
leu2-5,112::G196-Spt7::LEU2 
This study 
FUY907 
MATa ADE2  lys2Δ  his3-11 ura3-1 sgf73Δ::hphMX trp1-1::GBD-SgF73(D373-402 
aa)-3×flag3::TRP1 leu2-5,112::G196-Spt7::LEU2 
This study 
FUY908 
MATa ADE2  lys2Δ  his3-11 ura3-1 sgf73Δ::hphMX trp1-1::GBD-SgF73(373-402 
aa)-3×flag::TRP1 leu2-5,112::G196-Spt7::LEU2 
This study 
FUY927 
MATa ADE2  lys2Δ  his3-11 ura3-1 sgf73Δ::hphMX trp1-1Δ::GBD-3×flag::TRP1 
leu2-5,112::SPT7(1-1142)-G196::LEU2  
This study 
FUY928 
MATa ADE2  lys2Δ  his3-11 ura3-1 sgf73Δ::hphMX trp1-1::GBD-SGF73-3×flag::TRP1 
leu2-5,112::SPT7(1-1142)-G196::LEU2 
This study 
FUY929 
MATa ADE2  lys2Δ  his3-11 ura3-1 sgf73Δ::hphMX trp1-1::GBD-Sgf73(Δ373-402 
aa)-3×flag3::TRP1 leu2-5,112::SPT7(1-1142)-G196::LEU2 
This study 
FUY930 
MATa ADE2  lys2Δ  his3-11 ura3-1 sgf73Δ::hphMX trp1-1::GBD-Sgf73(373-402 
aa)-3×flag::TRP1 leu2-5,112::SPT7(1-1142)-G196::LEU2 
This study 
FUY944 
MAT@ ADE2   lys2Δ  trp1-1  his3-11 hmrΔ::bgl-bclΔ ura3-1::HMRΔ I +4×Gal4bs  at 
mat a2(ECONI)::URA3 leu2-5,112::SPT7-G196::LEU2 
This study 
FUY931 
MAT@ ADE2    lys2Δ  trp1-1  his3-11 hmrΔ::bgl-bclΔ ura3-1::HMRΔ I +4×Gal4bs  at 
mat a2(ECONI)::URA3 leu2-5,112::SPT7(1-1142)-G196::LEU2 
This study 
FUY1105 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1Δ::GBD-3×flag::TRP1 leu2-5,112::SPT20-G196::LEU2  
This study 
FUY1106 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1Δ::GBD-SGF73-3×flag::TRP1 leu2-5,112::SPT20-G196::LEU2 
This study 
FUY1107 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-Sgf73(373-402 aa)-3×flag::TRP1 leu2-5,112::SPT20-G196::LEU2 
This study 
FUY1108 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-Sgf73(Δ373-402 aa)-3×flag3::TRP1 leu2-5,112::SPT20-G196::LEU2 
This study 
FUY1109 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1Δ::GBD-3×flag::TRP1 leu2-5,112::RTG2-G196::LEU2  
This study 
FUY1110 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1Δ::GBD-SGF73-3×flag::TRP1 leu2-5,112::RTG2-G196::LEU2 
This study 
FUY1111 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-Sgf73(373-402 aa)-3×flag::TRP1 leu2-5,112::RTG2-G196::LEU2 
This study 
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FUY1112 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-Sgf73(Δ 373-402 aa)-3×flag3::TRP1 leu2-5,112::RTG2-G196::LEU2 
This study 
FUY1113 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1Δ::GBD-3×flag::TRP1 leu2-5,112::UBP8-G196::LEU2  
This study 
FUY1114 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1Δ::GBD-SGF73-3×flag::TRP1 leu2-5,112::UBP8-G196::LEU2 
This study 
FUY 1115 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-Sgf73(373-402 aa)-3×flag::TRP1 leu2-5,112::UBP8-G196::LEU2 
This study 
FUY 1116 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-Sgf73(Δ373-402 aa)-3×flag::TRP1 leu2-5,112::UBP8-G196::LEU2 
This study 
FUY 1117 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1Δ::GBD-3×flag::TRP1 leu2-5,112::SGF29-G196::LEU2  
This study 
FUY1118 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1Δ::GBD-SGF73-3×flag::TRP1 leu2-5,112::SGF29-G196::LEU2  
This study 
FUY1119 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-Sgf73(373-402 aa)-3×flag::TRP1 leu2-5,112::SGF29-G196::LEU2  
This study 
FUY1120 
MATa ADE2  lys2Δ  his3-11  leu2-5,112  trp1-1  ura3-1 sgf73Δ::hphMX 
trp1-1::GBD-Sgf3(Δ373-402 aa)-3×flag::TRP1 leu2-5,112::SGF29-G196::LEU2  
This study 
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Table. 2.2 Plasmid lists 
Plasmid   Comment 
pFOM84 pGBK-RC plus GBD-SGF73 (1-657aa.) (Oki et al., 2004) 
pFOM197 pGBK-RC plus GBD-SGF73 (Δ210-282 aa.) This study 
pFOM198 pGBK-RC plus GBD-SGF73 (Δ227-272 aa.) This study 
pFOM199 pGBK-RC plus GBD-SGF73 (Δ227-402 aa.) This study 
pFOM202 pGBK-RC plus GBD-SGF73 (Δ273-402 aa.) This study 
pFOM203 pGBK-RC plus GBD-SGF73 (Δ70-100 aa.) This study 
pFOM204 pGBK-RC plus GBD-SGF73 (Δ70-402 aa.) This study 
pFOM194 pGBK-RC plus GBD-SGF73 (Δ70-144 aa.) This study 
pFOM195 pGBK-RC plus GBD-SGF73 (Δ113-335 aa.) This study 
pFOM206 pGBK-RC plus GBD-SGF73 (273-402aa.) This study 
pFOM207 pGBK-RC plus GBD-SGF73 (336-459 aa.) This study 
pFOM208 pGBK-RC plus GBD-SGF73 (273-459 aa.) This study 
pFOM209 pGBK-RC plus GBD-SGF73 (336-402 aa.) This study 
pFOM210 pGBK-RC plus GBD-SGF73 (336-372 aa.) This study 
pFOM211 pGBK-RC plus GBD-SGF73 (373-402aa.) This study 
pFOM212 pGBK-RC plus GBD-SGF73 (336-356aa.) This study 
pFOM213 pGBK-RC plus GBD-SGF73 (357-385aa.) This study 
pFOM214 pGBK-RC plus GBD-SGF73 (386-402aa.) This study 
pFOM215 pGBK-RC plus GBD-SGF73 (352-395aa.) This study 
pFOM216 pGBK-RC plus GBD-SGF73 (336-395aa.) This study 
pFOM217 pGBK-RC plus GBD-SGF73 (352-402aa.) This study 
pFOM218 pGBK-RC plus GBD-SGF73 (336-385aa.) This study 
pFOM219 pGBK-RC plus GBD-SGF73 (357-402aa.) This study 
pFOM220 pGBK-RC plus GBD-SGF73 (378-388aa.) This study 
pFOM221 pGBK-RC plus GBD-SGF73 (378-386aa.) This study 
pFOM222 pGBK-RC plus GBD-SGF73 (382-392aa.) This study 
pFOM226 pGBK-RC plus GBD-SGF73 (382-389aa.) This study 
pFOM227 pGBK-RC plus GBD-SGF73 (373-395aa.) This study 
pFOM228 pGBK-RC plus GBD-SGF73 (378-394aa.) This study 
pFOM229 pGBK-RC plus GBD-SGF73 (373-394aa.) This study 
pFOM593 p404-GBD-SGF73-3xFLAG This study 
pFOM594 p404-GBD-sgf73 (373-402aa)-3xFLAG This study 
pFOM595 p404-GBD-SGF73Δ373-402aa-3xFLAG This study 
pFOM362 p415-GCN5 This study 
pFOM363 p415-gcn5E173H This study 
pFOM364 p415-gcn5F221A This study 
pRS415 Centromeric plasmid, LEU2 This study 
pFOM153 p404-3xFLAG This study 
pFOM596 pGBK-RC plus GBD-sgf73Δ373-402aa This study 
pFOM714 pRS405-G196-SPT7  This study 
pFOM717 pRS405-SPT7 (1-1333aa)-G196 This study 
pFOM716 pRS405-SPT7 (1-1142aa)-G196 This study 
pFOM713 pRS405-G196-Nterminal This study 
pFOM712 pRS405-G196-Cterminal This study 
pGBK-RC GBD only (Ito et al., 2000) 
pFOM582 p404-GBD-3xFLAG This study 
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Table. 2.3 Primers lists 
Primer name Primer sequence 
210-SGF73(207)-Rv CAAAGGATCTTCAATGAGTTGTGCATTC 
211-SGF73(442)-F AACGACGACAACGAAGATGATGATGA 
212-SGF73(627)-Rv GGAAGAGCTGAAGGTTTGAGGAG 
213-SGF73(847)-F GGTGCAGCTGCTGAGAAACG 
214-SGF73pro-379-F GTAAGACCTCATCGAGCCATCTATAG 
215-SGF73ter+213-Rv GTATTCGCTCTCTCCTACCCTTAT 
216-SGF73pro-686-F GGAGGAAACAGGCATTTCATGCAA 
217-SGF73ter+376-Rv CCTTGGGAAATATTCGGTATTTCATTCTC 
220-SGF73(678)-Rv TAAATGCTTTTCAGTTGGGTTTCTTTGTTTGAC 
221-SGF73(817)-F GATTATCATAGAGAACATCAAACAAAAATTGGTGC 
222-SGF73(813)-Rv TAGCAAGACGTCGTAGGGCTTG 
223-SGF73(816)-Rv TGCTAGCAAGACGTCGTAGGG 
224-SGF73(1205)-F CAGGATATACATCTCCAGGTTACGGT 
227-SGF73(1207)-F GGATATACATCTCCAGGTTACGGTG 
228-SGF73(301)-F GCATCTGGAAAAAGTAGCACAGATCC 
257-SGF73-HI(1006)F ATGGTGGatccAGTACTGTACACAATGGTAACAAT 
258-SGF73-(1206)PstIRv TGGAGcTGcAgATCaTGGTTTCACAGAAAAG 
263-SGF73-HI(817)F TCTTGggAtCcGATTATCATAGAGAACATCAAACA 
264-SGF73-(1375)PstIRv AGAAGCTGcagCTaTAGAGCTCTCTGTTGTTGTA 
358-51-KanMX(Rv)-611 CCATCTCATCTGTAACATCATTGGC 
359-52KanMX(F)-950 GTTGAACAAGTCTGGAAAGAAATGCATAAG 
498-SGF73(352)BamHI-F GACACGgatcCCTAACTCCTGAAGAGGAAACAA 
499-SGF73(356)StPstI-Rv AACCTcTGcaGTTTaCTCTTCAGGAGTTAGGTTAA 
500-SGF73(357)BamHI-F CTCCTGgAtccGAAACAACACAGGTTCTAAATGGG 
501-SGF73(372)StPstI-Rv ACCGTctgCagTtaTGGCAGTGGGAAAGATCGG 
502-SGF73(373)BamHI-F TCCCAggatCcCTAGAGTCAACGGTACTATCGTC 
503-SGF73(385)StPstI-Rv ATTCTctgcagTTaAGTCCTGTATCTAACTGACGA 
504-SGF73(386)BamHI-F GATACgGatCcAAATATTTTAGAATGAGGGAAATG 
505-SGF73(395)StPstI-Rv CACAGctgcaGAttAAGCAAACATTTCCCTCATTC 
522-SGF73(378-388)-F gatccCTATCGTCAGTTAGATACAGGACTAAATATTTTtGAcTGca 
523-SGF73(378-388)-Rv gTCaAAAATATTTAGTCCTGTATCTAACTGACGATAGg 
524-SGF73(378-386)-F gatccCTATCGTCAGTTAGATACAGGACTAAATAacTGca 
525-SGF73(378-386)-Rv gtTATTTAGTCCTGTATCTAACTGACGATAGg 
526-SGF73(382-392)-F gatccAGATACAGGACTAAATATTTTAGAATGAGGGAAtaGcTgca 
527-SGF73(382-392)-Rv gCtaTTCCCTCATTCTAAAATATTTAGTCCTGTATCTg 
528-SGF73(378)BamHI-F AGTCAggatccCTATCGTCAGTTAGATACA 
529-SGF73(394)PstI-Rv GAAAActgcagttaAAACATTTCCCTCATTCTAAA 
530-SGF73(382-389)-F gatccAGATACAGGACTAAATATTTTAGAtaGctGcA 
531-SGF73(382-389)-Rv gCtaTCTAAAATATTTAGTCCTGTATCTg 
308-SGF73-F CATCTATGGAATCTGCGAACACA 
309-SGF73-Rv TTGAGGAGTCCCAGTTTTCGA 
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2.2.2 Methods: 
2.2.2.1 Construction of Saccharomyces cerevisiae strains 
Deletion strains were obtained by homologous recombination using a KanMX gene cassette 
(Knock Out Strain Collection, Open Biosystems) flanked by the 200 bp upstream and 
downstream of the specific gene sequence. Disruption strains were further evaluated by PCR 
to confirm the deletion of target genes. The following figure demonstrated primer designing to 
evaluate deletion strains. 
 
 
 
Fig. 2.2 Deletion strains check by PCR 
 
The fragment containing SLIK-type Spt7 (residues 1–1142) or Spt7 (residues 1–1333) was 
cloned into the pRS405 vector with C-terminal or N-terminal fusion to the G196 tag, 
respectively. Genomic integration of the C-terminal or N-terminal G196 tag and another 
C-terminal tag (3xFLAG) was performed using standard methods involving transformation of 
yeast. Deletion and epitope-tagged strains were verified by PCR amplification of genomic 
GENEkanMX
358 817359814
③1465bp②1288bp
19329
7743
4254
2690
1882
1489
925
① ②marker ③
•spt8Δ::kanMX
•spt3Δ::kanMX
•sgf73Δ::kanMX
•ubp8Δ::kanMX
•sgf29Δ::kanMX
•gcn5Δ::kanMX
•pep4Δ::kanMX
•ada2Δ::kanMX
•ada3Δ::kanMX
•ahc1Δ::kanMX
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DNA and Western blot analysis, respectively. The genotypes of the strains used in this study 
are listed in Table 2.1 
 
2.2.2.2 Plasmid construction 
Conventional methods were used to construct plasmids from the pGBK-RC plasmid for 
domain analysis. The coding sequences of SGF73 were amplified from yeast genomic DNA 
using primers containing a 5’ BamHI site and a 3’ PstI site. For domain analysis, target amino 
acid-inserted and -deleted fragments were obtained by PCR amplification. DNA fragments 
were then separated using agarose gels and purified using a GFX
TM 
PCR DNA and Gel 
Purification Kit (GE). The purified PCR product was cloned into the pGBK-RC plasmid (Ito 
et al. 2000). Phosphorylated primer pairs against sequences just outside the target domain 
were designed and the rest of the plasmid was amplified and ligated, effectively deleting the 
target amino acids. TaKaRa EX Taq™ (TaKaRa) and KOD-FX (TOYOBO) DNA polymerase 
were used to amplify DNA fragments from the template plasmid. The sequences of the 
inserted and deleted fragments were verified by restriction endonuclease digestion and DNA 
sequencing. The primers used for domain analysis are listed in Table 2.3 and the plasmids 
used in this study are listed in Table 2.2. 
 
2.2.2.3 Mating assays 
Patch mating assays were performed as described previously (Donze et al. 1999). For mating 
assay our group constructed a MATα hmrΔ yeast strain which contain a plasmid with a Gal4p 
binding domain (GBD) inserted between HMR-E and a1 gene.  
 
 
Fig. 2.3 Gene cassete structure of mating test strains  
 
Expression of the MATa1gene at HMR was monitored by transferring cells to the plate 
containing MATa mating tester lawns. If the GBD fused protein does not maintain boundary 
a1
E
4x Gal4p
binding sequence
Reporter geneSilencer
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function, MATa1 gene at HMR is repressed resulting the MATα cell is capable of mating with 
a MATa cell and form diploid colony on selective plates. In the presence of a barrier blocked 
the spread of silencing. As a result the MATa1 gene at HMR is expressed and loss of mating 
ability. Patches of the appropriate strains were grown on YMD plates (lacking tryptophan) for 
2–3 days at 30°C. To monitor the mating ability of the cells, single colonies were transferred 
to YMD plates with adenine- and leucine-containing mating tester lawns (JRY19a) and grown 
to an OD600 of 2.0. For diploid colonies, the cells were allowed to grow at 30°C for 48 hours 
prior to photography. To perform this analysis, GBD-Sgf73 was carried between the HMR-E 
silencer and the a1 gene and monitor expression of a1 gene by the mating assay.  
 
2.2.2.4 a1 gene expression analysis  
Total RNA was isolated by acid phenol-chloroform extraction. Following reverse transcription 
with the High Capacity cDNA Reverse Transcription Kit (Life Technologies), cDNA was 
amplified in real time using the Applied Biosystems 7300 Fast Real-Time PCR system with 
SYBR Green (Power SYBR® Green PCR Master Mix, Life Technologies) as the detection 
dye. NTG1 was used as a normalization control to determine a1 gene expression in the 
relevant strains. We performed three independent experiments for all strains and the standard 
error was calculated. Real-time PCR steps were as follows: 95°C for 10 min (1 cycle), 95°C 
for 15 sec, and 60°C for 1 min (40 cycles). Following figure shows isolated RNA by acid 
phenol-chloroform on agarose gel 
 
 
 
Fig. 2.4 RNA extraction by phenol-chloroform method 
23 
 
2.2.2.5 Affinity purification of protein complexes 
To determine associated proteins with Sgf73 and boundary formational minimum region 
Sgf73 (373–402 aa; 3xFLAG tag was fused to the C-terminal of GBD-Sgf73, GBD-Sgf73 
(373–402 aa). FLAG-tagged GBD and FLAG-tagged GBD-Sgf73 (373–402 aa) yeast strains 
were also constructed as controls. The following figure will demonstrate C-terminal FLAG 
tagged system used in here. 
 
 
 
Fig. 2.5 FLAG tagged yeast strains used in this study 
 
Purification of FLAG-tagged proteins were carried out as previously described (Lida and 
Araki, 2004), with some modifications. Appropriate Yeast strains were grown in YPD 
medium at 30
○
C to an OD600 of 2. Yeast cells were collected by centrifugations and washed 
with 1xPBS buffer. Harvested cells were frozen in liquid nitrogen and make powder with 
bead beater (Shake Master, NEO). The powder was then resuspended in 0.8 ml lysis buffer 
[50 mM HEPES-KOH (pH 7.5), 300 mM KCl, 0.05% Tween-20, 0.05% NP-40, 10% glycerol, 
0.2 μg/ml pepstatin, 0.2μg/ml leupeptin, 1 mM PMSF, 2 mM β-glycerophosphate, 2 mM NaF, 
0.4 mM Na3VO4, 0.5 mM Na-pyrophosphate]. Collection of supernatant was performed by 
repeated centrifugation at 14000x g at 4
○
C for 20 mins. Protein extracts were adsorbed onto 
500 µl of Sepharose 4B Fast Flow (GE Health care) for 1 hr at 4
○
C with constant rotation. 
3xFLAG
Sgf73-3xFLAG
Sgf73
Sgf73 (373-402aa)
Sgf73(373-402 aa)-3xFLAG
Sgf73 (Δ373-402 aa)-3xFLAG
3xFLAG
3xFLAG
Sgf73 (Δ373-402 aa)
GBD
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Beads were pelleted and recovered supernatant was mixed with 30µl of anti-Flag-agarose 
(M2) beads (sigma) and rotated 3 hours at 4
○
C. The beads were washed 3 times with lysis 
buffer containing 0.1 mg/ml BSA, and repeated wash 3 more times to equilibrates the beads 
with 1ml cold lysis buffer. Purified proteins were resolved on a SDS-PAGE gel followed by 
silver staining and western analysis. Protein complexes were affinity purified as described 
above (Hatanaka et al. 2011).  
2.2.2.6 Mass spectrometry 
Purified protein complexes were electrophoresed on a 5–20% gradient sodium dodecyl sulfate 
polyacrylamide (SDS-PAGE) gel and visualized by silver staining with the SilverQuest
TM
 
Silver Staining Kit (Invitrogen). Protein bands were excised from the gel and digested with 
trypsin (Promega) for 16 hours at 37°C.
 
The collected peptides were analyzed by mass 
spectrometry as described previously (Sadaie et al. 2008). 
 
2.2.2.7 Western blotting analysis and immunoprecipitation 
Yeast strains were grown in YPD at 30°C to an OD600 of 2.00. The cells were harvested, 
washed in 1 ml cold PBS, and then collected by centrifugation at 4°C. SDS-PAGE loading 
buffer was added and the samples were heated for 3 minutes at 95ºC. For Western blotting, 
samples were electrophoresed on a 6% SDS-PAGE gel, electroblotted onto a PVDF 
membrane and visualized by standard methods. In addition to the FLAG tag, this study 
utilized a novel tag named G196 (manuscript in preparation) of submit , which is a 
polypeptide protein tag that can be added to proteins using recombinant DNA technology. An 
anti-DLVPR antibody can be used to detect N- or C-terminally tagged G196 fusion proteins 
by Western blot analysis. The samples were probed with HRP-conjugated anti-FLAG 
antibody, and an anti-G196 primary antibody and an anti-mouse HRP-conjugated secondary 
antibody. 
 
2.3 Results 
2.3.1 Domain analysis of the boundary function of Sgf73  
Based on genome-wide screening of approximately 6000 genes in S. cerevisiae, we isolated 
55 boundary-related genes (Oki et al. 2004). We performed deletion analysis of one of these 
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genes, Sgf73, to identify the minimum region necessary for its boundary function. To this end, 
GBD-Sgf73 was inserted between the HMR-E silencer and the a1 gene and expression of the 
a1 gene was monitored by mating assays in plates containing MATa tester lawns. Complete 
absence of barrier activity was indicated by the formation of diploid colonies due to silencing 
of the a1 gene. Barrier activity prevented the spread of transcriptional silencing, resulting in 
expression of the a1 gene and non-mating or little mating phenotypes [Fig. 2.6 (A)].  
The domains containing amino acids 70–104 and 227–272 of Sgf73 are zinc-finger motifs 
(ZnF1 and ZnF2, respectively) [Fig. 2.6 (B)] (Lai et al. 2010). The ZnF1 motif resides in the 
N-terminal region while the ZnF2 motif lies in the central region of Sgf73 (Lai et al. 2010). 
The N-terminal residues of Sgf73, which include the adjacent ZnF1 motif, play a key role in 
anchoring the deubiquitination module composed of Ubp8, Sus1 and Sgf11 to SAGA and 
SLIK (Kohler et al. 2008; Lee et al. 2009; Lai et al. 2010; Samara et al. 2010). ZnF2 of Sgf73, 
also called the SCA7 domain, is believed to bind the nucleosome and is implicated in 
chromatin interactions (Bonnet et al. 2010). The spacing of ZnF2 of yeast Sgf73 is different to 
that of its human homolog, Ataxin-7, which is necessary for binding to TFTC-STAGA 
(Helmlinger et al. 2004). The Hurt group reported that yeast Ataxin-7 maintains proper 
histone ubiquitination levels and plays a role in gene gating and mRNA export (Kohler et al. 
2008). Interestingly, it did not appear to have any role of zinc finger domains to maintain 
Sgf73 boundary function. Deletion of individual or both zinc-finger domains (ZnF1 and 
ZnF2) from this protein resulted in a non-boundary phenotype [Fig. 2.6 (B)].These data 
indicate that the zinc-finger domains are not important for the boundary function of Sgf73 and 
that the domain containing amino acids 336–402 mediates its boundary activity[Fig. 2.6 (B)].  
We then further pinpointed the domain responsible for the boundary function of Sgf73 [Fig. 
2.6 (C)]. Patch mating assays indicated that amino acids 373–402 of Sgf73 are vital for its 
boundary function. To confirm this, a 373–402 amino acid deletion strain was constructed and 
its phenotype was examined [Fig. 2.6 (D)].  
 Deletion of this minimal region completely abrogated the barrier function of Sgf73. These 
results strongly suggest that amino acids 373–402 are crucial for the boundary function of 
Sgf73.  
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Fig. 2.6 (A) Boundary screening system 
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Fig. 2.6 (B) Domain analysis of Sgf73 
 
 
 
Fig. 2.6 (C) Schematic presentation of domain analysis of Sgf73 
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Fig. 2.6 (D) Decided minimum region after domain analysis of Sgf73 
 
Fig. 2.6 (A). A schematic representation of boundary screening system where GBD-fused 
genes were inserted between HMR-E silencer and the a1 gene and examined boundary 
activity by monitoring of a1 gene expression. (Top) pattern showing absence of boundary 
function due to silencing of a1 gene. (Bottom) Boundary element Sgf73 block the spread of 
silencing by expressing a1 gene. X represent GBD fused gene. (B). Domain analysis of Sgf73. 
Zinc finger domain 1 (ZnF1) and Zinc finger domain2 (ZnF2) are indicated by a dotted box 
(70–104 aa) and a slash-marked box (227–272 aa), respectively. The first and last residues of 
each domain are numbered. Domain analysis of Sgf73 boundary function. Barrier activity is 
indicated by a non-mating phenotype; growth indicates a lack of barrier function. (C) 
Schematic depiction of Sgf73 domain analysis. The green box indicates the primary boundary 
region that was examined by patch mating assay. (D) Full-length Sgf73 is shown as 1–657 aa, 
and the bottom green box (373–402 aa) represents the minimum region necessary for 
boundary function. Deletion of this region (373–402 aa) is used as a negative control. All 
domains used in this study were cloned between HMR-E and the a1 gene of pGBK-RC, 
transformed into (ROY 2042).  
 
2.3.2 The minimum region of Sgf73 binds SAGA complex components 
To identify proteins that associate with Sgf73 and are necessary for its boundary function, we 
generated yeast strains expressing FLAG-tagged GBD-Sgf73 and FLAG-tagged GBD-Sgf73 
(373–402 aa). We also generated FLAG-tagged GBD and FLAG-tagged GBD-Sgf73 
(373–402 aa) yeast strains as controls. By using the same patch mating assay (Oki et al. 
1-657 (Full length)
GBD only
Δ373-402
373-402 
373 – LESTVLSSVRYRTKYFRMREMFASSFSVKP  – 402
N- -C
1 227 272 657 aa70 104
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2004), we confirmed that tagged GBD-Sgf73 and GBD-Sgf73 (373–402 aa) were functional 
(data not shown). All 3xFLAG-tag proteins were purified using anti-FLAG antibodies and 
eluted using FLAG peptides. To separate interacting proteins, FLAG-tagged samples were 
electrophoresed on a 8% SDS-PAGE gel and silver staining was performed. This revealed a 
band pattern similar to that of the SAGA complex components for both Sgf73 full-length 
protein and the minimal region (373–402 aa) [Fig. 2.7 (A)].  
To confirm the association of SAGA components with Sgf73, silver-stained protein bands 
were excised and subjected to in-gel trypsin digestion. The isolated proteins were then 
identified by LC-MS/MS analysis, which confirmed the presence of Tra1, Spt3, Spt7, Spt8, 
Ada1, Ada2, Ada3, Gcn5, Taf5, Taf6, Taf9, and Taf10. However, mass spectrometry failed to 
detect Rtg2 associated with GBD-Sgf73 (373–402 aa)-3xFLAG, whereas Spt8, a unique 
component of SAGA, was detected (Table. 2.4). Mass spectrometry also showed that the 
ubiquitin-specific protease, Ubp8, was associated with the full-length protein, but not with the 
minimal necessary region of Sgf73 (373–402 aa) (Table. 2.4). As an H2B deubiquitinating 
protease, Ubp8 is activated in the presence of the N-terminal zinc-finger-containing domains 
of Sgf73, Sgf11 and Sus1 (Kohler et al. 2008; Lee et al. 2009; Lai et al. 2010; Samara et al. 
2010). However, the zinc-finger-containing domain is not present in the minimum region 
(373–402 aa). It is possible that Ubp8 was unable to bind the truncated form of Sgf73 due to 
the absence of ZnF1. Mass spectrometry analysis also failed to detect Sgf11 and Sus1 
associated with full-length Sgf73. This result raises the possibility of smaller size or lower 
protein concentration; therefore mass spectrometry data could not detect those two SAGA 
components. 
Our mass spectrometry analysis could not be able to detect Sgf29 binding into full length 
Sgf73; moreover Rtg2 binding was recognized into GBD only; which were unusual. To 
make sure about mass spectrometry result we performed immunoprecipitation experiment 
[Fig. 2.7 (B)]. We chose Spt20, Ubp8, Sgf29 and Rtg2 for immunoprecipitation assay. 
Interestingly, our immunoprecipitation analysis could not find Rtg2 binding into GBD, full 
length Sgf73 and Sgf73 (373-402 aa) [Fig. 2.7 (B)]. Furthermore, our IP result recognized 
Sgf29 binding into full length Sgf73 (not detected by mass spectrometry) and Sgf73 (373-402 
aa) [Fig. 2.7 (B)].  
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Our mass spectrometry and immunoprecipitation result together further supported our idea 
about ubp8 that bind to N-terminal zinc-finger-containing domains of Sgf73 not our boundary 
formational minimal region Sgf73 (373-402 aa) because our IP result could not also detect 
ubp8 into our minimum region Sgf73 (373-402 aa) [Fig. 2.7 (B)]. 
 
 
 
Fig. 2.7 (A) Isolation of associated proteins 
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Fig. 2.7 (B) Immunoprecipitation assay 
 
Fig. 2.7 Affinity purification of Sgf73-interacting proteins. (A) Silver stain of the proteins 
isolated by FLAG purification. Lane 1, marker; Lane 2, GBD-3xFLAG (FUY614) (MW: 21 
kD); Lane 3, GBD-3xFLAG-Sgf73 (FUY615) (MW: 94.6 kD); Lane 4, GBD-3xFLAG-Sgf73 
(373–402 aa) (FUY617) (MW: 25.3 kD); Lane 5, GBD-3xFLAG-Sgf73 (Δ373–402 aa) (FUY 
616) (MW: 91 kD). (B) Interaction of Sgf73 (373-402 aa) with SAGA and SLIK components. 
Binding of Spt20, Rtg2, Ubp8 and Sgf29 to the Sgf73 (373-402 aa) were evaluated by 
C-terminaly fused G196 tag. Immunoblotting was carried out by using an anti-G196 antibody. 
Immunoprecipitations were prepared by FLAG purification. GBD: FUY1105, SGF73: 
FUY1106, Sgf73 (373-402 aa): FUY1107, Sgf73 (373-402 aa): FUY 1108 for Spt20 fusion. 
GBD: FUY1109, SGF73: FUY1110, Sgf73 (373-402 aa): FUY1111, Sgf73 (373-402 aa): 
FUY 1112 for Rtg2 fusion. GBD: FUY1113, SGF73: FUY1114, Sgf73 (373-402 aa): 
FUY1115, Sgf73 (373-402 aa): FUY 1116 for Ubp8 fusion. For Sgf29 fusion; GBD: 
FUY1117, SGF73: FUY1118, Sgf73 (373-402 aa): FUY1119, Sgf73 (373-402 aa): FUY 
1120. 
Rtg2-G196
Ubp8-G196
Sgf29-G196
Spt20-G196
S
G
F
7
3
input
G
B
D
S
G
F
7
3
IP
G
B
D
S
g
f7
3
 (
3
7
3
-4
0
2
)
S
g
f7
3
 (

3
7
3
-4
0
2
 )
S
g
f7
3
 (
3
7
3
-4
0
2
 a
a
)
S
g
f7
3
 (

3
7
3
-4
0
2
 )
a-G196
32 
Table. 2.4 SAGA /SLIK components detected by mass spectrometry 
Protein 
Name 
M.W. 
(KDa) 
GBD-3xFLAG GBD-Sgf73 
-3xFLAG 
GBD-Sgf73 
(373-402aa)-3xFLAG 
Tra1 433 × ○ ○ 
Spt7 153 × ○ ○ 
Taf5 89 × ○ ○ 
Ada3 79 × ○ ○ 
Sgf73 73 × ○ ○ 
Spt20 68 × ○ ○ 
Spt8 66 × ○ ○ 
Rtg2 66 ○ ○ × 
Taf12 61 × ○ ○ 
Taf6 58 × ○ ○ 
Ada1 54 × ○ ○ 
Ubp8 54 × ○ × 
Gcn5 51 × ○ ○ 
Ada2 51 × ○ ○ 
Spt3 39 × ○ ○ 
Sgf29 29 × × ○ 
Taf10 23 × ○ ○ 
Taf9 17 × ○ ○ 
Sgf11 11 × × × 
Sus1 11 × × × 
 
Presence and absence of corresponding protein is indicated by ○ and ×respectively 
 
2.3.3 The HAT module facilitates the boundary function of Sgf73 
FLAG purification together with mass spectrometry identified a number of proteins belonging 
to the SAGA complex. Based on these results, we sought to determine whether any of the 
subunits of the SAGA complex contribute to the boundary activity of GBD-Sgf73. To 
examine this, we deleted SAGA subunits from the relevant strains and examined boundary 
function by the same patch mating assay as was used for genome-wide screening (Oki et al. 
2004). Thus, if GBD-Sgf73 and GBD-Sgf73 (373–402 aa) failed to maintain boundary 
function in the absence of a specific protein, reporter gene a1 expression was repressed and 
the cells formed diploid colonies on the selection plates. 
33 
   
Fig. 2.8 Boundary activity in disruption strains. Patch mating assay was performed in WT, 
spt8(FUY596), sgf29(FUY364), Spt3 (FUY594), sgf73 (FUY131), gcn5(ROY2120), 
ada2 (ROY2220), ada3 (ROY2240), pep4 (FUY392) and ahc1 (FUY592) strains to 
identify the genes necessary for the boundary function of GBD-SGF73 and GBD-Sgf73 
(373–402 aa). GBD and GBD-Sgf73 (Δ373-402 aa) were used as negative controls for 
boundary formation. (+) and (-) indicate constructs with and without Gal4-binding sites, 
respectively; WT, wild type. 
 
The disruption-strain mating assay revealed that deletion of the HAT components ada2, 
ada3 and gcn5 resulted in complete loss of boundary function of GBD-Sgf73 and GBD-Sgf73 
(373–402 aa), while loss of the HAT components sgf29 and TBP spt3 had no effect on the 
barrier activity of either GBD-Sgf73 or GBD-Sgf73 (373–402 aa) (Fig. 2.8). Deletion of 
another component, Pep4, which cleaves Spt7 and mediates SLIK formation, also induced a 
non-mating phenotype. In addition, deletion of the unique ADA complex component, ahc1, 
and the chromatin remodeling protein, chd1, also kept boundary function. This suggests that 
only the HAT core is important for Sgf73-mediated boundary function.  
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2.3.4 The boundary function of Sgf73 is influenced by the HAT activity of Gcn5 
The SAGA HAT module consists of Ada2, Ada3 and the HAT catalytic component Gcn5 
(Rodriguez-Navarro 2009). To determine whether the HAT activity of Gcn5 is important for 
the boundary function of Sgf73, we generated point mutant strains in which the HAT activity 
of Gcn5 was disrupted and assessed their effect on boundary function using the patch mating 
assay (Oki et al. 2004). The Sgf73 full-length protein and minimum region (373–402 aa) 
maintained boundary function when the HAT activity of Gcn5 was intact (p415-GCN5); 
however, boundary activity was completely lost in the point mutant strains (p415-gcn5 E173H 
and p415-gcn5F221A) [(Fig. 2.9 (A)]. (Liu et al. 2005). We next determined the level of a1 
gene expression level in the point mutant strains by real-time PCR and hat mutant strains 
showed very low a1 gene expression [(Fig. 2.9 (B)] 
These results agreed with the patch mating assay. Taken together, HAT activity of Gcn5 
appears to have a crucial role in regulating the boundary function of Sgf73. 
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Fig. 2.9 (A) Boundary activity of Gcn5 point mutant 
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(B) 
 
 
Fig. 2.9 (B) Evaluation of a1 gene expression of gcn5 point mutant 
 
Fig. 2.9 Boundary activity of the hat mutant. Patch mating assay shows loss of boundary 
activity in the hat mutant. (A) GBD, GBD-Sgf73 and GBD-Sgf73 (373–402 aa) were 
transformed with pRS415, p415-GCN5 (functional HAT activity of GCN5), p415-gcn5 
E173H (HAT activity deficient) and p415-gcn5 F221A (HAT activity deficient) plasmids. (B) 
a1 gene expression levels were determined by real-time PCR and normalized to the level of 
NTG1. Error bars show the standard deviation between three independent colonies. Mean 
values are plotted.  
 
2.3.5 SAGA and SLIK are both important for the boundary activity of Sgf73 
SAGA is a large multi-protein complex that participates in both the acetylation and 
deubiquitination of histones. SAGA is a 1.8 MDa HAT complex in yeast (Grant et al. 1997). 
SAGA and SLIK share all components except Spt8 and Rtg2. Spt8 is a unique component of 
the SAGA complex, whereas the SLIK complex lacks Spt8 but possesses Rtg2, which is 
absent in SAGA. Both complexes share Spt7, but the SLIK complex contains a form of Spt7 
(SPT7
SLIK
) that is truncated at the C-terminus (Hoke et al. 2007), (Spedale et al. 2010), 
whereas Spt7 is not truncated in the SAGA complex (SPT7
SAGA
). Following Figure showed 
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the difference between SAGA and SLIK complex (Fig. 2.10). 
 
 
 
Fig. 2.10 Difference between SAGA And SLIK complex 
 
To clarify which complex is important for Sgf73 boundary function, we fused the G196 tag 
to the N-terminus of Spt7. Thus, both SPT7
SAGA 
and SPT7
SLIK
 could be detected by an 
anti-G196 antibody. Western blotting showed that SPT7
SAGA
 was associated with both 
full-length Sgf73 and truncated Sgf73 (373–402 aa) [Fig. 2.11 (A)]. SPT7SLIK was also 
detected with the N-terminal G196 tag, but only at a very low concentration [Fig. 2.11 (A)]. 
To further confirm this association, we fused the G196 tag to the C-terminus of Spt7, so that 
only SPT7
SLIK
 (C-terminal truncated) would be detected. Interestingly, immunoblot assay also 
detected SPT7
SLIK
 associated with truncated Sgf73 [Fig. 2.11 (B)]. This result suggests that 
both SAGA and SLIK play a role in the boundary function of Sgf73. 
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Fig. 2.11 (A) Interaction of Sgf73 with SAGA and SLIK type Spt7 
 
 
 
Fig. 2.11 (B) Interaction of Sgf73 with SLIK type Spt7 
 
Fig. 2.11. Interaction of Sgf73 with SAGA- or SLIK-type Spt7. (A) The full-length 
(Spt7
SAGA
) and truncated (Spt7
SLIK
) forms of SPT7 were examined by fusion of a G196 tag to 
the N-terminus for Sgf73, Sgf73(373–402 aa) and Sgf73 (373–402 aa). Immunoblotting was 
performed using an anti-G196 antibody. Immunoprecipitates (IPs) were prepared by FLAG 
purification. GBD: FUY905, SGF73: FUY906, Sgf73 (373–402 aa): FUY908, Sgf73 
SPT7SAGA
SPT7SLIK
IP
S
G
F
7
3
input
S
g
f7
3
 (
3
7
3
-4
0
2
 a
a)
S
G
F
7
3
G
B
D
G
B
D
a-G196
S
g
f7
3
 (

3
7
3
-4
0
2
 a
a)
S
g
f7
3
 (
3
7
3
-4
0
2
 a
a)
S
g
f7
3
 (

3
7
3
-4
0
2
 a
a)
IP
S
G
F
7
3
input
S
G
F
7
3
SPT7SLIK
G
B
D
G
B
D
a-G196
S
g
f7
3
 (
3
7
3
-4
0
2
 a
a)
S
g
f7
3
 (

3
7
3
-4
0
2
 a
a)
S
g
f7
3
 (
3
7
3
-4
0
2
 a
a)
S
g
f7
3
 (

3
7
3
-4
0
2
 a
a)
(B) 
(A) 
38 
(373–402 aa): FUY907. (B) Spt7SLIK was monitored by immunoblotting of C-terminal 
G196-tagged Spt7 using an anti-G196 antibody. IPs were prepared by FLAG purification. 
GBD: FUY927, SGF73: FUY928, Sgf73 (373–402 aa): FUY930, Sgf73 (373–402 aa): 
FUY929. FUY944 and FUY931 were used as positive controls for the size of Spt7
SAGA
 and 
Spt7
SLIK
, respectively, and ROY2042 was used an untagged control (data not shown). 
 
2.4 Discussion  
The highly conserved SAGA protein complex is well known for its acetylation and 
deubiquitination activities. Histone acetylation is regulated by the HAT module, composed of 
Ada2, Ada3 and Gcn5, and deubiquitination is performed by the DUB module, consisting of 
the ubiquitin-specific protease, Ubp8, and three additional proteins: Sgf11, Sus1 and Sgf73. 
Sgf73 is primarily known for its role in anchoring the deubiquitination module to the SAGA 
and SLIK complexes (Kohler et al. 2008; Lee et al. 2009; Lai et al. 2010; Samara et al. 2010). 
However, in this study, we examined the mechanism by which Sgf73 fulfills its role as a 
boundary protein. 
Domain analysis was performed to determine which region of Sgf73 is important for 
boundary activity, which revealed that the minimal region necessary for the boundary function 
of Sgf73 lies between amino acids 373–402 (Fig.2.6). This domain retained boundary 
function even when the zinc-finger domains were deleted. 
 Sgf73 is a component of the SAGA and SLIK complexes (Lee & Workman 2007). 
However, which of these is important for the boundary function of Sgf73 remained unclear. 
We used a FLAG purification system to determine whether Sgf73 interacts with SAGA or 
SLIK, and found that Sgf73 bound both complexes (Fig. 2.7 and Table 2.4). However, mass 
spectrometry data failed to detect Rtg2 associated with the minimum region of Sgf73 
(373–402 amino acids), although Spt8 was detected in association with both full-length Sgf73 
and the minimum domain. Spt8 is important for the interaction of SAGA with TATA-binding 
proteins (Sterner et al. 1999; Larschan & Winston 2001; Laprade et al. 2007; Mohibullah & 
Hahn 2008; Weake et al. 2011). Although this seems to contradict the results of our 
immunoblot analysis (Fig. 2.11), it is possible that Rtg2 was simply not detectable under the 
conditions used for affinity purification.  
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According to mass spectrometry results, the SAGA component Ubp8 was unable to bind to 
the minimum region of Sgf73 (373–402 aa), but did bind the full-length protein (Table 2.4). In 
previous studies, we observed that Ubp8, together with Sgf11 and Sus1, can bind to the 
N-terminus (1–104 aa) of Sgf73 (Kohler et al. 2008; Lee et al. 2009; Lai et al. 2010; Samara 
et al. 2010). We hypothesize that Ubp8 could not bind the minimum region due to the absence 
of the N-terminal domain. Furthermore, we were also unable to detect Sgf11 and Sus1 by 
mass spectrometry due to their small size or lower protein concentration (Table 2.4).  
We next performed a disruption-strain mating experiment to determine the specific SAGA 
subunits necessary for the boundary function of Sgf73. We deleted various subunits of 
SAGA/SLIK/ADA complexes from the wild-type strains. Boundary function was completely 
lost when ada2, ada3 or gcn5 were deleted (Fig.2.8). However, the deletion of other 
components showed no effect on Sgf73-mediated boundary function. Thus, it appears that the 
HAT module is important for controlling the spread of transcriptional silencing by Sgf73.  
   The catalytic component, Gcn5, together with Ada2 and Ada3, catalyzes acetylation by 
creating an open chromatin structure for the binding of transcription factors and the 
pre-initiation complex (Grant et al. 1999; Balasubramanian et al. 2002; Rodriguez-Navarro 
2009; Bian et al. 2011). Deletion of another important SAGA component, Sgf29, did not show 
any effect on the barrier activity of Sgf73. Thus, although Sgf29 is important for the 
recognition of methylated H3K4 by SAGA (Bian et al. 2011), it does not appear to be 
important for the boundary function of Sgf73. To validate our initial findings of the role of the 
HAT core on boundary function, we next examined Sgf73-mediated boundary function in 
mutant strains in which Gcn5 activity was inhibited. gcn5 mutant strains lost boundary 
function when HAT activity was disrupted [Fig. 2.9 (A)]. A similar result was obtained by 
real-time PCR, which revealed decreased levels of a1 gene expression in the gcn5 point 
mutant strains and increased a1 gene expression levels in the non-mutant strains [Fig. 2.9 (B)]. 
Together, the results of disruption-strain mating assays and gcn5 point mutation analysis 
indicate that the HAT activity of Gcn5 is crucial to Sgf73-mediated boundary activity.  
Previous biochemical study demonstrated that the SAGA complex contains the longer form 
of Spt7, while the C-terminal truncated form of Spt7 is present in the SLIK complex (Hoke et 
al. 2007; Spedale et al. 2010). Spt8 binds the C-terminus of Spt7 in the SAGA complex 
(Pray-Grant et al. 2002) (Fig. 2.10). Thus, we sought to clarify the role(s) of SAGA and 
SLIK in the boundary formation function of Sgf73. To this end, we fused the truncated form 
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of yeast Spt7 (SPT7
SLIK
) and full-length Spt7 (SPT7
SAGA
) to a C-terminal and N-terminal 
G196 tag, respectively. After interacting proteins were purified using a FLAG-tag purification 
system, immunoblotting with a G196 antibody detected SPT7
SAGA
 associated with both the 
full-length and truncated Sgf73 proteins [Fig. 2.11(A)]. SPT7
SLIK 
was also associated with 
both the full-length and truncated forms of Sgf73 [Fig. 2.11(B)]. Thus, both the SAGA and 
SLIK complexes appear to be important for the boundary activity of Sgf73 because both bind 
the minimum region. However, the question of whether SAGA and SLIK work together or 
independently remains unresolved. It is difficult to speculate that when SAGA comes to 
facilitate boundary activity of Sgf73, SLIK also come or not or only SLIK complex alone can 
do perform this boundary activity. It is possible that boundary formation is influenced by both 
complexes. However, the mechanism(s) by which SAGA and SLIK contribute to native 
boundary formation remain unknown.  
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Chapter 3 
Phenotypic effect and regulation of high erucic acid transgene in 
DH rapeseed (Brassica napus) population 
 
3.1 Introduction 
Erucic acid (22:1) obtained from the seed oil of high erucic acid rapeseed (HEAR) is a 
sought-after raw material used by the oleochemical industry (Scarth and Tang 2006). It is 
used in the production of plastic films, nylon, lubricants and emollients, detergent (Craig 
and Millan 1995). Currently available conventional HEAR cultivars contain only about 50% 
22:1 in the seed oil. A substantial increase of the 22:1 content of the rapeseed oil would 
significantly reduce processing costs and could increase market prospects. However, in 
Brassica napus and related Brassica species, the content of erucic acid in the seed oil is 
limited by the fact that erucoyl moieties are typically excluded from the central sn-2 
position of the triacylglycerol molecule. This limitation is due to the specificity of the 
rapeseed lysophosphatidic acid acyltransferase (Bn-LPAAT), which is incapable of utilizing 
erucoyl-CoA as an acyl donor (Taylor et al. 1992). The exclusion of erucic acid from the 
sn-2 position implies a threshold of 66% erucic acid in the seed oil (Frentzen 1993; Katavic 
et al. 2001).  However, as indicated above, in reality only much lower erucic acid contents 
in the seed oils are achieved, which indicates that the -ketoacyl-CoA synthase (KCS; fae1 
gene) activity, the first enzyme responsible for the fatty acid elongation from oleic acid 
(18:1) to eicosenoic acid (20:1) and to erucic acid (Cassagne et al. 1994) may be limiting 
erucic acid content in the seed oil. In rapeseed there are two fae1 genes, the Bnfae1.1 and 
the Bn-fae1.2, which correspond to the fae1 gene of the parental species B. rapa 
(A-genome) and B. oleracea (C-genome), respectively (Ecke et al. 1995; Fourmann et al. 
1998). These two fae1 loci have been shown to contribute to a different degree to the total 
erucic acid content in the seed oil. 
While de novo fatty acid synthesis occurs in plastids, the synthesis of very long chain 
monounsaturated fatty acids (VLCMFAs) is located in the cytosol and catalyzed by a 
membrane-bound fatty acid elongation (FAE) complex on the endoplasmic reticulum. The 
initial substrate for the elongation is oleic acid (18:1). The 18:1 content in the seed oil of 
HEAR is, at around 15%, already quite low compared with the 60% of ‘00’- quality/canola 
oil. This could be indicative of a low cytosolic pool of available oleoyl-CoA, which may 
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limit the elongation (Domergue et al. 1999). To answer the question, whether the 
availability of oleoyl-CoA is limiting to 22:1 synthesis; therefore a cross of high oleic acid 
rapeseed (HOAR) to HEAR was made to recombine the genes for high 22:1 with those for 
high 18:1. However, this did not show significant change of 22:1 acid content but 3-5% 
increase in 20:1 content (Sasongko and Möllers 2005). To find out the solution of the 
limitations, an experiment was undertaken with DH population produced from the following 
cross: 
 
Transgenic Line     x Non-transgenic  
High erucic acid rapeseed line HEAR-TNKAT  High Erucic and Low polyunsaturated  
(With 1 transgene copy Ld-LPAAT-Bn/fael)                  (With 1 major and 2-3 minor genes for low  
       PUFA content) 
 
                                                      
                                                                F1 (4-5 genes with one transgene copy) 
 
Microspore culture with in vitro colchicine                   
treatment  
 
                                                                90 DH lines  
 
The objectives of the present experiment were to study the inheritance of erucic acid content 
in the segregating transgenic DH population and to evaluate the variation and estimate the 
heritability and phenotypic effect of different phenological and quality traits in the DH 
population.             
 
3.2 Materials and methods  
3.2.1 Plant materials 
The plant materials used in the present study were 90 sister double haploid (DH) lines and 
their parents of rapeseed (Brassica napus L.). The DH lines were developed following 
microspore culture technique (Fletcher et al. 1998) using the buds of the F1 plants of the 
cross involved transgenic resynthesised high 22:1 rapeseed line TNKAT (Han et al. 2001) 
and non-transgenic high erucic acid and low polyunsaturated fatty acid (HELP) line 6575-1 
(Sasongko and Möllers 2005).  
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3.2.2 TNKAT 
A resynthesised (RS306) transgenic winter rapeseed line which was derived from 
interspecific crosses between Yellow Sarson (Brassica rapa) and cauliflower (Brassica 
oleracea sp. capitata; Han et al. 2001). The above mentioned resynthesised line was used 
for transformation following Agrobaterium mediated genetic transformation protocol. One 
chimeric transgene copy of the LPAAT-gene from Limnanthes douglasii and the fae1-gene 
from Brassica napus cv. Askari was cloned and expressed in a single cassette vector 
pHAN2 both under control of the strong seed specific napin promoter and reporter gene 
nptII with 35S promoter (Han et al. 2001). 
 
3.2.3 6575-1HELP (High Erucic and Low Polyunsaturated fatty acid) 
This line is F4 seed generation of winter rapeseed with 18:1 (27%), PUFA; 18:2+18:3 (7%) 
and high 22:1 (50%) (Sasongko and Möllers 2005) obtained from a cross between winter 
rapeseed cv. Maplus and four sister DH winter rapeseed lines (DH VIIE5, DH XIXG10, 
DHXXIID9 and DH XXXB2) having high 18:1 and low glucosinolates (GSL) content (00, 
WR) that were derived from the same F1 plant of the cross {F4 7065/94NPZ x (453 x 
Hk102) x Gö9}. This 6575-1HELP seed material was provided by Dr. Christian Möllers, 
University Göttingen. 
 
3.2.4 Methodology 
A green house experiment was performed in S1 (safety 1) green house in the department of 
Crop Sciences, division Plant Breeding, Georg-August University, Göttingen from August 
2006 to April 2007. Ninety double haploid (DH) along with their parents as control, were 
sown in multipot trays, with five replications for each line and parents, containing T-soil 
(Fruhstrofer Erde, P
H 
= 6.5) and allowed to grow them for 3 weeks in S1 green house. Three 
weeks later, seedlings were transferred to vernalisation chamber had 4ºC temperature with 8 
hours (hrs) light for 8 weeks. Plantlets from multipot tray were transferred to 9 cm diameter 
pots containing normal compost soil in the S1 green house after 8 weeks vernalisation. 
Green house experiment was conducted in RCBD (Randomized complete block design) 
with 3 replications using the 3 vernalised plants for each DH line and parents. Each steel 
bench inside the green house was represented a complete block consisted all genotypes (DH 
and parents) and each pot like as plot.  
Plantlets were allowed to grow in the green house providing 16 hrs day light by using 
additional 400 Watt Sodium-steam lamp. Temperature during the day and night was 20ºC 
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and 15ºC respectively. Plants were bagged providing selfing bag at the stage of single 
flower open for individual plant. Seeds were harvested when they were mature, 
characterized by changing the siliques colour turned to brown. Seeds were collected and 
stored in special coloured paper bag for easy identification of transgenic material and kept 
in 4ºC chamber of S1 storage. Data were collected on phenological and quality traits (oil, 
protein, glucosinolates, fatty acid composition, trierucin and sn-2 specific fatty acid 
mixtures of the seeds). Seed oil, protein and glucosinolate content, expressed on seed dry 
matter basis were determined by using Near-Infrared Reflectance Spectroscopy (NIRS) with 
the calibration equation raps2001.eqa developed by Tillmann (2007) and values were 
adjusted for 14 mm PVC adapter using the regression equation provided by Dr. Christian 
Möllers. The trierucin (C69; EEE) content of the seed samples was determined by high 
temperature gas liquid chromatography (HT-GLC) analysis of fatty acid esters according to 
the method describe by Möllers et al. (1997). The fatty acids composition of the samples 
was determined by gas liquid chromatography (GLC) analysis of fatty acid esters.  
 
3.2.5 Data collection  
Data were collected in this study on the basis of two categories, firstly on the basis of the 
phonological traits including days to flowering and days to maturity. Secondly on the basis 
of quality traits including oil, protein, fatty acid composition, trierucin and sn-2 specific 
fatty acid mixtures of the seeds of DH lines and their parents. 
a. Phenological traits 
i. Days to flowering 
Days to flowering was counted considering the date of transfer the plantlets in green house 
to the date of opening of the first flower in individual plant. 
ii. Days to maturity 
Days to maturity was counted considering the date of transfer the plantlets in green house to 
the date at which most of the siliques colour turned to brown in individual plants. 
b. Quality traits 
i. Oil and protein content analysis by NIRS (Near infrared reflectance spectroscopy) 
Seed oil and protein content, expressed on seed dry matter basis (9% water) were 
determined by using Near-infrared reflectance spectroscopy (NIRS) with the calibration 
equation raps2001. Eqa developed by Tillmann (2007) and values were adjusted for 14 mm 
PVC adapter using regression equations provided by Dr. Christian Mollers. Around 450-500 
mg of seeds per sample was scanned with NIRS monochromator model 6500, using special 
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adapter made of PVC (4 mm thick, Ө 38 mm ) with a central hole of 14 mm to scan seed 
samples. This adapter was inserted into the standard NIRS small ring cup. The seeds were 
hold in the position from the back with an appropriate size disposable paper board back that 
was placed to a normal size sample cup back to hold the seeds. Spectra was recorded 
between 400 and 2500 nm, registering the absorbance  values log(I/R) at 2 nm intervals for 
each sample. 
 
ii. Trierucin analysis by HT-GLC (High Temperature Gas Liquid Chromatography) 
In this study trierucin was analyzed by high temperature Gas liquid chromatography. Seed 
material (150 mg) was measured on an analytical balance and placed into a polypropylene 
tube with screw caps with one stainless steel rod (1.2 cm length, 0.5 cm diameter) per tube. 
1.5 ml iso-octane was added for each sample and seed were homogenized for 1 min in a 
mini-Beat-Beater-8 (BioSpec products, Inc.,OK, USA). We can chose high speed of Beat 
-Beater without destroying the tube. Then keep samples for 20 mins at room temperature. 
Centrifuge 150xg (1000 rpm) for 5 mins. Collect the supernatant around 180 µl and then 
transfer into a septum vial for injection (ca. 2 ul) into the GLC PERKIN ELM ER 8420 with 
autosampler (AS8300). Rest of the supernatant (iso-octane with oil) was used for fatty acid 
analysis described in the next section. A triglyceride standard T-9154 of the company 
SIGMA-ALDRICH containing trierucin (EEE, 22:1) was used as a lipid standard for 
trierucin analysis. The content of one ampule (50 mg) was dissolved in 1 ml iso-octane. The 
gas chromatography condition was equipped with a fused silicone capillary column 
RTX-65TG (Restek no. 17005) 15 m x 0.25 mm i.d. (0.1 um film thickness). Conditioning 
of the new column: carrier gas: 40 kPa hydrogen, injector:200 ºC, detector: 350 ºC, split: 
ca.1: 50, hold the column 15 min at 40ºC, start with 1ºC/min until 350 ºC, hold at 350ºC for 
60 minutes. Separation conditions for the RTX-65TG column: carrier gas: 160 kPa 
hydrogen, injection and detection temperature: 365ºC, oven temperatures hold 5 min at 340 
ºC start with 2ºC/min until 360ºC, attenuation: 1x8. Trierucin content was calculated as 
percentage (%) based on following formula: 
 
 
 
 
% of trierucin =
Area of trierucin
Total area of  all triglycerides
X 100
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iii. Fatty acid analysis by GLC (Gas liquid chromatography) 
The fatty acid composition of the samples was determined by Gas liquid chromatography 
(GLC) analysis of fatty acid esters. Remaining supernatant (iso-octane with oil) after taking 
for trierucin analysis, was transferred to a new tube and left on a hot plate at 37.5 ºC for 
overnight to evaporate and then added 500 ul of Na-methylate in methanol (0.5 mol/1) [9 ml 
5.56 mol sodium methylate in 1 l methanol+ 10 ml isoctane add 100 ml with methanol p.a. 
+100 ul 1% bromocresol green in methanol]. Shaking and vortex until the solution was 
clear and then incubates 20 minutes for complete transmethylation of the fatty acid from oil. 
Add 200 ul of 5% NaHSO4 solution and 300 ul iso-octane to the sample, and vortex. 
Collect the 180 ul upper phase following centrifugation at 150xg (1000 rpm) and then 
transfer to the septum vial and inject (ca. 2 ul) into the GLC (PERKIN ELMER 8420, San 
Jose, CA, USA). The gas chromatography was equipped with a fused silicon capillary 
column FFAP 25 m x 0.25 mm i.d. (0.1 um film thickness). The column temperature was 
210 ºC and the carrier gas was 150 kPa H2 at the split rate of 1:70, and injection/detector 
temperature was 230 ºC. Individual fatty acids, such as palmitic, stearic, oleic, linoleic, 
linolenic, eicosenoic, erucic acid were determined by GLC and expressed as % of total fatty 
acids. 
 
3.2.6 Statistical analysis 
Analysis of variance was performed with PLABSTAT software version 2F (Utz 2007) using 
the following model:
 ijjiij
rgY 
 
where: Yij was observation of genotype i in replicate j; 
gi and rj were the effects of genotype i in the replicate j, respectively and ij was the residual 
error of genotype i in replicate j. Multiple mean comparisons were made with StatGraphics 
Plus for Windows 3.0 (Statistical Graphics Corp., Rockville, USA). The number of transgene 
copy segregated among the DH lines were calculated using χ2- test for a fixed ratio hypothesis 
described by Gomez and Gomez (1976). Simple correlation coefficients were calculated 
using PLABSTAT software version 2F (Utz 2001). Direct and indirect path coefficients of 
the path coefficient analysis were calculated as described in Lynch and Walsh (1998). 
 
3.3 Results and Discussion 
3.3.1 Phenotypic variation among DH lines  
The DH population showed highly significant variations for all phenological and quality 
traits; days to flowering and maturity, oil, protein and different fatty acids content in seed oil 
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(Table. 3.1). Erucic acid was the most prominent fatty acid, accounting for 47.1% of the 
total fatty acid content followed by oleic acid (19.7%), PUFA (15.9%), eicosenoic acid 
(9.9%) and SFA (4%). A considerable quantitative variation was found for erucic acid, oleic 
acid, PUFA and eicosenoic acid content ranging from 34.6 - 59.1%, 9.1-36.5, 5.6-27.9 and 
3.9-18.9, respectively. This variation may be explained by differently effective alleles 
responsible for oleic acid elongation to erucic acid (Jönsson 1977) and the factors 
modifying the erucic acid content. Erucic acid showed medium heritability. High 
heritabilities were found for days to flowering and PUFA content. Frequency distribution of 
erucic acid content showed four classes with 1:3:3:1 segregation (Fig. 3.1) indicating that 
this trait was controlled by alleles of 3 loci in this DH population rather than only two genes 
in additive manner, found by Kirk and Hurlstone (1983) and Getinet et al. (1997). This 
could be expected due to the genetic make-up of the parents, that produced F1 used for 
microspore culture. F1 contained at least two major genes and other alleles of the 
endogenous erucic acid loci segregating for erucic acid content in DH population. Presence 
of such alleles could be confirmed by DNA sequencing of all fatty acid elongation (fae1) 
and desaturase (fad2) genes were combined in F1 used for DH production.  
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Table. 3.1. Means, ranges, variance components and heritabilities (h
2
b) of days to flowering, maturity, oil and protein content and different fatty 
acids (%) of 90 DH lines derived from the cross between TNKAT × HELP, along with parental lines. Values are the mean of three plants. 
 
 
Days to 
flowering 
Days to 
maturity 
% oil 
content 
% protein 
content 
Fatty acid content (%) 
SFA 18:1 PUFA 20:1 22:1 24:1 VLMUFA 
Mean 33 103 40.5 29.6 4.0 19.7 15.9 9.9 47.1 1.2 58.2 
Minimum 16 85 28.3 20.6 2.4 9.1 5.6 3.9 34.6 0.2 47.9 
Maximum 97 164 50.7 37.5 5.9 36.5 27.9 18.9 59.1 2.3 68.8 
TNKAT 35 110 37.8 30.9 4.1 15.9 20.8 10.0 46.1 1.1 b 57.2 
HELP 26 90 42.4 28.1 3.8 26.8 8.4 7.9 50.4 0.8 59.1 
 2g 230.4** 205.5** 12.5** 5.9** 0.3** 17.9** 22.8** 5.9** 19.2** 0.05** 10.6** 
2r 0.9 10.9 0.12 0.1 0.0 0.09 0.15 0.0 0.1 0.0 0.1 
2e 44.3 92.0 7.7 3.7 0.1 4.9 2.2 1.9 7.5 0.04 5.0 
h
2
b 0.83 0.69 0.61 0.61 0.68 0.78 0.91 0.75 0.72 0.55 0.67 
 
**
 Significant at p=0.01; [SFA = 16:0 + 18:0; PUFA = 18:2 + 18:3; VLMUFA = 20:1 + 22:1 + 24:1] 
2g    genetic variance, 
2
r variance for replication, 
2
e error variance and h
2
b heritability in broad sense  
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Fig. 3.1 Transgression for erucic acid content in the DH population derived from a cross 
between transgenic high erucic acid (TNKAT) and non-transgenic High Erucic and Low 
Polyunsaturated fatty acid (HELP) rapeseed lines in comparison to parents. 
 
3.3.2 Effect of the Ld-LPAAT gene on erucic acid content and other traits 
All the DH lines of the population were grouped into two categories on the basis of the 
presence and absence of Ld-LPAAT transgene confirmed by PCR amplification (Nath et al. 
2007). It was also confirmed by estimating of trierucin (EEE) content in case of Ld-LPAAT 
positive. Among the DH lines, Ld-LPAAT positive and Ld-LPAAT negative were 54 and 36 
lines, respectively (Table. 3.2 and Fig. 3.2). The segregation pattern of Ld-LPAAT gene was 
investigated by chi-square (χ2) test for fixed ratio hypothesis, the calculated value of 
chi-square was 3.6, which was non-significant indicating that the DH population segregated 
in a 1:1 ratio for one copy of Ld-LPAAT transgene. The effect of transgene was investigated 
by comparing the mean between two groups of DH lines (Ld-LPAAT positive and 
Ld-LPAAT negative) using least significant difference (LSD) test. The values of mean 
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difference of two groups indicated that transgene had significant effect but in negative 
manner (-2.3%) on 22:1 content. On the other hand, statistically significant positive 
differences were observed for Ld-LPAAT gene in case of PUFA (3.0%) content (Table. 3.3). 
Reduction of oleic acid content is the indicator of utilization of this fatty acid for elongation 
by transgene, which is the limiting factor for erucic acid biosynthesis (Bao et al. 1998, 
Domergue et al. 1999). However, reduction of erucic acid content about 2% in DH positive 
group was unexpected; it seems that transgene has no affect to change the erucic acid 
content dramatically. The results of other experiments also showed that there was only a 
minor increase in erucic acid content due to LPAAT gene (Katavic et al. 2001, Han et al. 
2001). 
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Table. 3.2 Comparison between the transgenic and non transgenic lines for different phenological and seed quality traits and the segregation 
pattern of transgene in the DH population derived from the cross between TNKAT × HELP. 
Genotypes N 
Mean value of the traits 
Days to 
flowering 
Days to 
maturity 
% Oil 
content 
% Protein 
content 
SFA 18:1 PUFA 20:1 22:1 24:1 VLMUFA 
DH Ld-LPAAT 
positive  
54 32 102 39.8 29.7 4.1 18.2 17.1 11.0 46.2 1.2 58.4 
DH Ld-LPAAT 
negative  
36 35 104 41.6 29.4 3.9 21.9 14.1 8.3 48.5 1.2 57.9 
Mean difference 
 
 -3* -2 NS -1.8* 0.3 NS 0.2 NS -3.7* 3.0* 2.8* -2.3* 0.0 NS 0.5 NS 
LSD (0.05)  2.8 5.2 1.2 0.8 0.2 0.9 0.6 0.6 1.2 0.1 0.9 
Chi-square (χ20.05)  3.6 NS      One copy transgene segregate at 1:1 ratio 
*, NS significant at p=0.05 and non significant, respectively [SFA = 16:0 + 18:0; PUFA = 18:2 + 18:3; VLMUFA = 20:1 + 22:1 + 24:1] 
 
  
 1X
 2X
 21 XX 
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Fig. 3.2 Frequency distribution of erucic acid content of two groups of DH lines (Ld-LPAAT positive and Ld-LPAAT negative) in the DH 
population derived from a cross between transgenic high erucic acid (TNKAT) and non-transgenic (HELP) rapeseed lines along with parental 
means. 
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3.3.3 Effect of PUFA content on erucic acid content and other traits 
Since, Ld-LPAAT transgene did not show any considerable effect on erucic acid content, in 
a next step it was investigated the effect of PUFA content on erucic content and other traits. 
The effect of PUFA content was investigated by comparing the mean between two groups of 
DH lines (low PUFA and high PUFA content) using least significant difference (LSD) test. 
Mean PUFA content of the low and high PUFA class indicated that PUFA alleles had 
significant effect (3.7%) to increase 22:1 content (Table. 3.3 ). The mean difference of two 
groups indicated that low PUFA alleles also have positive effect on days to flowering (3 
days), oil content (1.8%) and oleic acid content (5.6%). On the other hand, statistically 
significant negative differences were observed for low PUFA alleles in case of protein 
(-1.6%), SFA (-0.7%) and PUFA (-8.1%) content. There were no statistical differences for 
days to maturity, 20:1, 24:1 and VLMUFA content (Table. 3. 3). 
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Table. 3.3 Comparison between low PUFA (≤15.9%) and high PUFA (>15.9%) content DH lines for different phenological and seed quality 
traits in the DH population derived from the cross between TNKAT × HELP. 
Genotypes N 
Mean value of the traits 
Days to 
flowering 
Days to 
maturity 
% Oil 
content 
% Protein 
content 
SFA 18:1 PUFA 20:1 22:1 24:1 VLMUFA 
DH with low PUFA 
content 
41 35 104 41.7 28.7 3.6 22.8 11.4 9.7 49.2 1.2 60.0 
DH with high 
PUFA content  
49 32 102 39.5 30.3 4.3 17.2 19.5 10.1 45.5 1.2 56.8 
Mean difference 
 
 3* 2 NS 2.2* -1.6* -0.7 * 5.6* -8.1* -0.4 NS 3.7* 0.0 NS 0.5 NS 
LSD (0.05)  2.8 4.0 1.2 0.8 0.2 0.9 0.6 0.6 1.1 0.1 0.9 
*, NS significant at p=0.05 and nonsignificant, respectively [SFA = 16:0 + 18:0; PUFA = 18:2 + 18:3; VLMUFA = 20:1 + 22:1 + 24:1] 
 1X
 2X
 21 XX 
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The scatter plots showing 22:1 vs. other important fatty acids and trierucin content in the 
DH population indicated the presence of high 22:1 DH lines  with a considerable variation 
in other important fatty acids and trierucin content as an example (Figure. 3.4 a-d). The 
scattered plot for 22:1 vs. trierucin showed clear two groups and weak correlation (rs = 0.15), 
but excluding the group for zero trierucin content showed strong positive correlation 
between erucic acid and trierucin content.  
 
 
 
 
Fig. 3.4 (A-D) Example of scattered plots of fatty acid compositions and trierucin content of 
90 DH lines compare with their parents (each point is the mean of 3 plants) derived from a 
cross between TNKAT × HELP. ** indicates significance at P= 0.01 probability. 
 
 
 
 
 
(A) (B) 
(C) (D) 
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3.3.4 Comparisons of mean among parents and selected best DH lines in the DH 
population 
Mean comparisons were done among the means of three selected DH lines with the means 
of parents using multiple range test at 95% LSD to find out whether the selected DH lines 
were significantly different from their parents for different phenological and quality traits. 
The mean values were the mean of three plants each genotype. DH line IV-10-F-6 contained 
the highest amount erucic acid (59.1%), VLMUFA (68%) and trierucin (8%) with lower 
amount of SFA, 18:1 and PUFA. The other two DH lines XI-10-D-6 and IX-10-C-8 
contained 57 and 56% erucic acid respectively, which were also statistically higher than 
both of the parents TNKAT (46%) and HELP (50%) respectively (Table. 3.4). DH line 
XI-10-D-6 showed the highest values for days to flowering and maturity and oil content that 
were 95, 145 days and 42% respectively. These mean values were statistically different 
from both of the parents for days to flowering and maturity but oil content was equal to the 
HELP parent (Table. 3.4). The best DH line, IV-10-F-6 exhibited mean values for days to 
flowering (35 days) and maturity (118 days) and oil content (36%) which were similar to 
the transgenic parent TNKAT. The other DH lines IX-10-C-8 was similar to the 
non-transgenic parent HELP for days to flowering (28 days) and maturity (91 days) and oil 
content (43%) (Table.3.4). DH line IV-10-F-6 contained the highest amount of protein 
(31%) which was similar to TNKAT parent followed by the DH lines XI-10-D-6 and 
IX-10-C-8, were similar to non transgenic HELP parent (Table. 3.4). Only the DH line 
IV-10-F-6 showed higher amount of trierucin (8%) content compared to transgenic parent 
TNKAT and other DH lines. 
60 
Table. 3.4 Mean comparisons among parents and the best three selected DH lines based on erucic acid content from DH population derived from 
the cross between TNKAT × HELP for different phenological and seed quality traits after multiple range test at 95% LSD. 
Genotype Days to 
flowering 
Days to 
maturity 
% Oil 
content 
% protein 
content 
Fatty acid composition (%) 
SFA 18:1 PUFA 20:1 22:1 24:1 VLMUFA Trierucin(EEE) 
TNKAT 35.7 b 110.7 b 37.8 b 30.9 a 4.1 a 15.9 d 20.8 a 10.0 a 46.1 d 1.1 bc 57.2 d 6.1 b 
HELP 26.7 c 90.0 c 42.4 a 28.1 b 3.8 b 26.8 a 8.4 cd 7.9 b 50.4 c 0.8 c 59.1 c 0.0 
IV-10-F-6 35.7 b 118.3 b 36.6 b 31.3 a 2.6 e 17.5 c 9.1 c 7.8 b 59.1 a 1.9 a 68.8 a 8.0 a 
XI-10-D-6 95.0 a 145.7 a 42.2 a 27.8 b 3.4 c 14.5 d 12.8 b 7.9 b 57.6 ab 1.4 b 66.9 a 5.7 b 
IX-10-C-8 28.3 bc 91.3 c 43.6 a 26.8 b 3.1 d 23.5 b 7.0 d 6.4 c 56.6 b 1.4 b 64.4 b 3.9 b 
SFA = 16:0 + 18:0; PUFA = 18:2 + 18:3; VLMUFA = 20:1 + 22:1 + 24:1 
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Chapter 4 
 Conclusion  
Epigenetics is a heritable change in gene expression caused by non-genetic 
mechanisms instead of by alteration of DNA sequences. We follow different kinds of 
epigenetic regulation mechanism like histone modification, chromatin and nucleosome 
remodeling, DNA methylation in eukaryote. Chromatin post translational modification 
and chromatin remodeling activities are critical for all aspects of gene regulation, DNA 
replication and DNA repair after damage. Epigenetic regulation can occur at 
transcription or posttranscriptional level. Epigenetic changes can be cell specific or 
tissue specific and can persist throughout a cells life and can be passed on to multiple 
generations. Many studies reported that epigenetic gene regulation is involved in 
different kinds of diseases of human. Silencing is one of the epigenetic gene regulation 
mechanism that is independent of DNA sequence. In this study, firstly I have focused 
on yeast Sgf73 which can delimit silencing spreading and perform boundary function at 
silenced HMR region. Yeast, a model of eukaryote, is a unicellular organism. So, it is 
easy to characterize. The eukaryotic chromosomes are comprised of structurally and 
functionally distinct domains that are often located in close proximity to one another. 
The euchromatin form of DNA is transcriptionally active and maintains an open 
chromatin structure via the actions of promoter, enhancers, and locus control region 
sequences. By contrast, heterochromatin is composed of a condensed chromatin 
structure that is generally transcriptionally repressed. Chromatin barriers prevent 
silenced chromatin domains from spreading into active domains. In S. cerevisiae there 
are four transcriptionally silent regions (HML, HMR, rDNA and telomere). In this study 
our boundary assay is focused on HMR region  
The budding yeast Saccharomyces cerevisiae contains active and inactive chromatin 
separated by boundary domains. Previously, we used genome-wide screening to identify 
55 boundary-related genes. In this study, firstly I have characterized Sgf73, a boundary 
protein that is a component of the SAGA (Spt-Ada-Gcn5 acetyltransferase) and SLIK 
(SAGA-like) complexes. These complexes have histone acetyltransferase (HAT) and 
histone deubiquitinase activity, and Sgf73 is one of the factors necessary to anchor the 
64 
deubiquitination module. Sgf73p consists of 657 amino acids. Here, I carried out 
domain analysis of Sgf73 and determine the minimum region which plays key role for 
boundary activity. The minimal region essential for the boundary function of Sgf73 lies 
between amino acids 373–402. Catalytic component, Gcn5, together with Ada2 and 
Ada3 catalyzes histone acetylation and deubiquitination is performed by the the 
ubiquitin-specific protease, Ubp8, and another three additional proteins: Sgf11, Sus1 
and Sgf73. From the previous study ZnF1 domain of Sgf73 is known for its role in 
anchoring the deubiquitination module to the SAGA and SLIK complexes But 
minimum region, Sgf73 (373-402) does not include the domain involved in anchoring 
the deubiquitination module, suggesting that the histone deubiquitinase activity of 
Sgf73 is not important for its boundary function. Next, Sgf73-mediated boundary 
function was analyzed in disruption strains in which different protein subunits of the 
SAGA/SLIK/ADA complexes were deleted. Deletion of ada2, ada3 or gcn5 (a HAT 
module component) caused complete loss of the boundary function of Sgf73 but 
deletion of ubp8 did not show any effect on Sgf73 boundary function. Furthermore, 
Sgf73 full domain and boundary formational minimal region; Sgf73 (373-402 aa) also 
lost barrier function when gcn5 point mutation was performed. Disruption strain mating 
together with gcn5 point result together suggests that histone acetylation activity is 
important for its boundary function not ubiquitination. SAGA or SLIK which of these is 
important for the boundary function of Sgf73 was unknown. The importance of SAGA 
or SLIK complex for the boundary function of Sgf73 was also analyzed. Western blot 
analysis detected both the full-length and truncated forms of Spt7, suggesting that both 
the SAGA and SLIK complexes appear to be important for the boundary activity of 
Sgf73 because both can bind into the minimum region. However, the question of 
whether SAGA and SLIK work together or independently remains unknown. Further 
research will be necessary to resolve this paradox. Following figure demonstrating our 
model of how Sgf73 perform its boundary function. 
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Fig. 4 .1 Model suggesting the mechanism of boundary activity of Sgf73 
 
Secondly, in this study I characterize 90 doubled haploid (DH) lines which come 
from F1 plants of the cross between transgenic rapeseed plants with high erucic acid 
and nontrangenic with low polyunsaturated fatty acid (HELP) plant material. Wild-type 
rapeseed contains erucic acid (22:1) a major component in the seed oil. It was 
considered as toxic element for human consumption. Therefore, Canola or '00'-quality 
rapeseed with low contents of erucic acid was derived through spontaneous mutated 
recessive alleles at the two loci that control the elongation of oleic acid. However, from 
the last decade, high erucic acid rapeseed (HEAR) cultivars have regained interest for 
industrial purposes. In the present study, 90 DH lines derived from F1 plants of the cross 
Ld-LPAAT- Bn-fae1 over expressing transgenic rapeseed plants with high erucic acid 
and low polyunsaturated fatty acid (HELP) plant material along with parental lines were 
grown in 3 replication in the S1 green house. The main objective was to study the 
inheritance of erucic acid content in the segregating transgenic DH population and to 
evaluate the variation and heritability for different phenological and quality traits such 
as: days to flowering and maturity, oil, protein and different fatty acids content in the 
DH population. Large variation was found for erucic acid content in DH population 
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varied from 34.6% to 59.1%. Genetic variance components were large and significant 
for all traits. The segregation pattern of erucic acid content showed 1:3:3:1 separation 
suggesting erucic acid content was controlled by the alleles of three loci in the DH 
population. Transgene Ld-LPAAT-Bn-fae1 showed negative effect (-2.7%) to change 
the erucic acid content in the DH population. This result suggesting that there was no 
effect of Bn-fae1 for increasing the erucic acid content or the absence of 
β-ketoacyl-CoA synthase (KCS) activities required for initiating fatty acid elongation 
from 18:1 to 22:1. On the other hand PUFA (Poly Unsaturated Fatty Acid) had effect to 
increase the erucic acid content up to 3.7%. In presence of transgene Ld-LPAAT showed 
limited activities to produce trierucin (8% instead of probable 20%) in the selected best 
DH line. The selected DH lines showed increase in erucic acid content (59.1%) 
compared to parental lines TNKAT (46.1%) and HELP (50.4%). Highest amount of 
erucic acid might be achieved due to introgression of PUFA alleles with those of the 
strong alleles of the indigenous erucic acid loci, because transgene showed negative 
effect on erucic acid.  There was no adverse effect of the high erucic content on other 
phenological traits in the selected best DH line. In conclusion the result of this study 
showed that erucic acid is inherited by alleles of three loci. The variation of erucic acid 
has been achieved due to the combination of alleles of two indigenous erucic acid loci 
with alleles of PUFA. Low in PUFA content could contribute markedly to increase 
erucic acid than the transgene construct present in DH lines. The selected DH line 
having 59% erucic acid could be source material for crossing to other high erucic acid 
transgenic line to increase the erucic acid content. 
 
 
 
 
 
  
67 
Appendices   
Protocol  
Purification of PCR product for Ligation 
1) Add an equal volume of PCR product membrane binding Solution.  
2) Place Mini-column on the Collection Tube.  
3) Move PCR product and membrane binding Solution into Mini-column, 1min 
incubates.  
4) Centrifuged at 14,000 rpm for 1min and then discard the liquid in the Collection 
tube. 
5) Add 500μl of Membrane Wash solution. 
6) Centrifuge at 14,000 rpm, room temperature, 1min. Discard the liquid in the 
Collection tube. 
7) Add 500μl of Membrane Wash solution.  
8) Centrifuge at 4,000 rpm, room temperature, 5min. Discard the liquid in the 
Collection Tube.  
9) Centrifuge at 14,000 rpm, room temperature, 1min.  
10) Move Mini column to the blank and clean eppen.  
11) Add a reasonable amount of TE Buffer.  
12) Incubate 1min.  
13) Centrifuge at 14,000 rpm, room temperature, 1min.  
14) Electrophoresis check.  
 
Purification of DNA from gel for ligation 
1) Carry out gel electrophoresis with samples.  
2) Cut the desired band from gel and transfer to an eppen-tube.  
3) According to the weight of gel add Membrane Binding Solution and vortex (10 mg 
gel equal with 10 ul Membrane Binding Solution).  
4) Kept at 60 ° C until gel completely dissolved.  
5) Place a Minicolumn onto Collection Tube.  
6) Move all liquid to Minicolumn, 1min incubate.  
7) Centrifuge at 14,000 rpm, room temperature, 1min. Discard the liquid in the 
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Collection tube.  
8) Add 500 ul of Membrane Wash solution.  
9) Centrifuge1 at 4,000 rpm, room temperature, 1min. Discard the liquid in the 
Collection tube.  
10) Add 500 ul of Membrane Wash solution.  
11) Centrifuge1 at 14,000 rpm, room temperature, 5min. Discard the liquid in the 
Collection tube.  
12) Centrifuge at 14,000 rpm, room temperature, 1min  
13) Transfer mini-column to the DNase free Eppen tube. 
14 Add a reasonable amount of TE Buffer and incubate 1min.  
15) Centrifuge at 14,000 rpm for 1 min 
16) Electrophoresis check 
 
Ligation and E.coli transformation 
1) Mix the followings into eppentube 
Vector           proper quantity 
Insert            proper quantity  
2x ligation mix    5 ul 
Total            10 ul 
2) 16°C 30 min. 
3) Then add 100ul competent cell to the eppentube. 
4) On ice, 20min. 
5) 42°C, 45sec. 
6) On ice, 5min. 
7) Room temperature, 2min. 
8) Add 200ul SOC and mix. 
9) Keep at 37°C for 30min. 
10) Spread on LB plate (including antibiotics such as ampicillin or Kanamycin). 
11) 37°C, overnight. 
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Plasmid Extraction (alkaline method)  
1) E. coli grows in 5 ml of LB medium (37°C, 220 rpm, overnight)  
2) Collect cells into 1.5 ml eppen-tube by repeated centrifuge at 9,000 rpm for 5 min  
3) Add Solution I 100 l, vortex well to mix.  
4) Add Solution II 200 l, mix gently on ice. 
5) Add Solution III 150 l, mix gently.  
6) 3 ~ 5 min, on ice.  
7) 12,000 rpm, 4°C, 5 min centrifuge. 
8) Collect the water phase into the new eppen-tube.  
9) Equal volume of Phenol / Chloroform was added and vortex.  
10) 12,000 rpm, room temperature, 5 min centrifuge. 
11) Collect the water phase into the new eppen-tube. 
12) Add 2 ~ 2.5 times volume of 99% ethanol, and vortex.  
13) 12,000 rpm, room temperature, 10 min centrifuge. 
14) Remove supernatant.  
15) Add 200 ul of 70% ethanol.  
16) 13,000 rpm, room temperature, 10 min centrifuge  
17) Remove supernatant and then vacuum drying (or dried naturally). 
18) Add 50ul TE (in RNase) and mixed. 
19) Electrophoresis check. 
 
Solution I (Keep at 4 °C)  
 4.4% glucose 
 2.5 mM Tris-HCl (pH 8.0)  
 1mM EDTA (pH 8.0)  
 
Solution II (made just before experiment) 
 0.2N NaOH   
 1% SDS  
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Solution III (Sterile with filter) 
 30 ml Potassium acetate 
 5.75 ml Glacial acetic acid 
 14.25 ml Sterile water 
 
Restriction enzyme treatment  
1) Mix the following solution.  
 Sample * Sample * 
 10×Buffer 3ul 10×Buffer 3ul 
 restriction enzyme 1ul restriction enzyme 1 1ul 
 Sterile water * restriction enzyme 2 1ul 
 Total 30ul Sterile water * 
  Total 30ul 
* The amount of sample and sterile water will be changed depending on purpose.  
** Buffer type would be changed depend on the relative activity of restriction enzyme. 
2) Keep at 37°C for 2hours. 
3) Electrophoresis check
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DNA Sequencing 
To perform DNA Sequencing we used DYEnamic ET Terminator Cycle Sequencing Kit 
(GE Healthcare) or BigDye terminator 3.3 Cycle sequencing Kit (ABI).  
DYEnamic ET 
1). Mix the following solutions 
Sequencing reagent premix     2.0ul 
Primer (2pmol/ul)            0.6ul  
Template DNA (200ng)       1.0ul 
d.d.water                   6.4ul 
Total volume               10.0ul 
2) PCR 
95°C  20sec 
25cycle           50°C  1 5sec 
60°C  1min 
4°C unlimited time 
3) Transfer PCR product into 1.5 ml eppen tube. 
4) Add 1ul 125 mM EDTA and 1ul 3M NaOAc. 
5) Add 30ul 100% EtOH and Mix. 
6) Keep 4°C, 15min. 
7) 14,000rpm, 20min centrifuge. 
8) Discard the supernatant. 
9) Rinsed by 70%EtOH 
10) Vacuum dry (or dried naturally) 
11) Add 20 ul Hi-Di formamide and Mix 
12) Keep at 95°C for 3min. 
13) Keep on ice for 5min,. 
14) Analyze DNA samples to know the sequence 
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Genomic DNA extraction  
1) The budding yeast was cultured in 5ml YPD medium (30°C, 220rpm, overnight) 
2) Collect cells into eppentube with repeated centrifugation at 3,500 rpm, 3 min 
3) Add 1ml sterile water  
4) Centrifuge at 6,000 rpm, room temperature, 1min.  
5) Add the following and 10min vortex   
       400ul Winston Solution  
       Approximately 200ul beads  
       300ul of Phenol / Chloroform  
6) Centrifuge at 14,000 rpm, room temperature, 5min.  
7) Collect the supernatant to a new eppen-tube. 
8) Add 300ul of Phenol / Chloroform.  
9) Centrifuge at 14,000 rpm, room temperature, 5min. 
10) Collect the water phase into a new eppen-tube. 
11) Add 1ml of 100% ethanol. 
12) Centrifuge at 14,000 rpm, room temperature, 15min. 
13) Remove supernatant.  
14) Add 1ml of 70% ethanol.  
15) Centrifuge at 14,000 rpm, room temperature, 5min. 
16) Supernatant removed, vacuum drying (or dry naturally) 
17) Add 100 ul of TE+ RNase (with a final concentration of 20ug/ul) to mix well.  
18) Stock at -20°C. 
Winston Solution (Sterile with filter)  
2% TritonX-100 
1% SDS 
0.1M NaCl  
10mM Tris-HCl (pH8.0)  
1mM EDTA  
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Budding yeast transformation 
1) Culture some yeast into 5ml YPD medium overnight (preculture) 
2) Take a small amount of precultured yeast into new 5ml YPD medium. 
3) Wait until OD600 = 0.7 ~1.00 
4) Transfer yeast to 15ml tube, centrifuge at 3,000 rpm, room temperature, 5min. 
5) Discard the supernatant and add 5ml of 1×TEL and vortex.  
6) Room temperature, 30 min mix.  
7) Centrifuge at 3,000 rpm, room temperature, 1min. 
8) Discard the supernatant; add 500ul of 1 x TEL and transfer the liquid to new eppen 
tube. 
For liner DNA  
9) Add 5ul ssDNA and 30ul liner DNA. 
10) Add 500ul 70% PEG400, pipette.  
11) Keep at room temperature for 60min.  
12) Add 100ul DMSO.  
13) Keep at 42°C for 5min.  
14) Centrifuge at 5,000 rpm, room temperature, 1min,.  
15) Remove the supernatant. 
16) Add 900ul of YPD liquid, cultured for 2 hours.  
17) Centrifuge at 5,000 rpm, room temperature, 1min. 
18) Discard 800ul.  
19) Spread the rest of liquid on YPD + antibiotic (such as G418) medium plate.  
For Plasmid 
9) Add 2ul ssDNA and 1ul plasmid, mix by pipette man.  
10) Add 500ul 70% PEG400, pipette.  
11) Keep at room temperature for 60min.  
12) Add 100ul DMSO.  
13) Keep at 42°C for 5min.  
14) Centrifuge at 5,000 rpm for 1min (room temperature)  
15) Remove the supernatant. 
16) Add 100ul of sterile water and spread on YMD + amino acids medium plate.  
17) Culture at 30°C, 2 ~ 3days. 
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RNA extraction from S.cerevisiae (Hot Phenol) 
1) Culture yeast in 5ml YPD or 5ml YMD medium at 30°C. 
2) Wait until OD600 =0.7 for YPD medium or OD600 =0.5 for YMD medium.  
(All manipulations should be performed at 4 °C) 
3) Collect cell by centrifugation at 3,500 rpm for 7 min  
4). Add 1ml DEPC water to dissolve cell and transfer to 1.5ml eppentube.  
5) Centrifuge at 6,000 rpm, 1min. 
6) Remove the supernatant. (If necessary, store the pellet in nitrogen liquid). 
7) Add 400ul AE buffer to dissolve pellet again. 
8) Add 40ul 10% SDS. 
9) Add 440ul Phenol and vortex for 30 sec. 
10) Keep at 65°C for 4 min. 
11) On ice. 
12) Centrifuge at 14,000rpm, 4°C, 5min. 
13) Transfer the water-layer to new eppen tube. 
14) Add the same volume Phenol/Chloroform and vortex. 
15) Centrifuge at 14,000rpm, 4°C, 5min. 
16) Repeat 14 and 15 step. 
17) Add 44ul 3M NaOAC and 1ml 100% EtOH. 
18) Keep at -20°C for 20min. 
19) Centrifuge at 14,000rpm, 4°C, 15min. 
20) Remove the supernatant. 
21) Rinse by 70% EtOH. 
22) Dry. 
23) Eluted by 50 ul DEPC water  
24) Freeze in liquid nitrogen and then store at -80°C.  
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Degradation of DNA in the RNA (DNase-treated) 
Deoyribonuclease (RT Grade) for Heat Stop (NIPPONGENE) was used to carry out the 
DNase treatment. Mix the following solutions. 
 
 
  
 
 
 
 
    
 
1) Incubate at 37 ºC for 15min 
2) Add 5µl Stop solution. 
3) Incubate at 70 ºC for 10min. 
Reverse transcription (make cDNA ) 
High-Capacity cDNA Reverse Transcription Kit (ABI) was used to carry out reverse 
transcription. 
1) Mix the following solutions in the eppentube. 
 
10 x RT buffer 2 µl 
25 x dNTPs 0.8 µl 
10 x RT Random Primers 2 µl 
MultiScribe
TM
Reversetranscriptase 1 µl 
DEPC’d water 4.2 µl 
Total 10 µl 
 
2) Then add 10µl RNA sample (DNA free) to the above eppentube. 
3) Carry out the following PCR. 
25 ºC       10 min 
 
37 ºC       120 min 
Total RNA  2 µl 
10 x DNase (RT Grade) buffer 
II 
5 µl 
Deoyribonuclease (RT Grade) 1 µl 
DEPC’d water 42 µl 
Total 50 µl 
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95 ºC        5 min 
 
                    4 ºC         Unlimited time 
4) cDNA sample is obtained 
 
 Prepare cDNA for RT-PCR. To carry out RT-PCR qPCR MasterMix Plus for SYBR 
Green I and 7300 Real Time PCR System are used.  
1) Dilute cDNA with 180ul TE buffer or DEPC’d water. 
2) Mix the following solutions. 
 
Total cDNA 5 µl 
5 µM each primer set 3.6 µl 
2 x reaction buffer 10 µl 
Water 1.4 µl 
Total 20 µl 
 
3) Carry out RT-PCR according to the following conditions. 
50 ºC       2 min 
 
                    95 ºC        10min 
 
95 ºC       15sec 
60 ºC        1min 
 
 
Dissociation Stage 
 
4) Analysis of RNA expression
40cycle 
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ChIP assay for yeast cells 
Day 1 
1) Culture yeast cells in YPD medium at 30 ºC, 220 rpm. 
2) When OD600=1.0-2.0, collect cells by centrifuge at 4,000 rpm, 5min. 
3) Remove the supernatant. 
4) Add 100ml Cross linking buffer and dissolve the pellet by pipetman. 
5) Transfer to Triangular flask. Add proper quantity 16% Paraformaldehyde until the 
final concentration of Paraformaldehyde is 1%. 
6) Shake for 30min at room temperature. 
7) Add 5ml 2.5 M glycin. 
8) Centrifuge at 4,000 rpm, 5min, RT. 
9) Remove the supernatant.  
10) Dissolve the pellet by Wash buffer 50ml/DTT 150 µl. 
11) Centrifuge at 4,000 rpm, 5min, RT. 
12) Remove the supernatant. 
13 On ice. 
14) Dissolve the pellet by Spheroplast buffer 10 ml / DTT 10 µl. 
Carry out OD600 measurement of 15ul sample dissolved in 1ml 1% SDS (OD600=0, 
when 15ul Spheroplast buffer is dissolved in 1ml 1% SDS). 
15) Dissolve Zymalaze in Spheroplast buffer and add into the liquid.  
16) Shake sample and measure its OD600, untill OD600 decrease to 1/10. 
17) Add 20 ml Pipes / sorb buffer. 
18) Centrifuge at 3,000 rpm, 5min, RT. 
19) Remove the supernatant. 
Keep on ice for the experiment below.  
20) Add PBS 5 ml / PMSF 12.5 µl and mix gently. 
21) Centrifuge at 3,000 rpm, 5min, 4 ºC. 
22) Remove the supernatant. 
23) Add HEPES / TritonX-100 5m l / PMSF 12.5 µl / Leupeptin 1 µl / Pepstatin 1 µl to 
dissolve pellet again. 
24) Centrifuge at 4,000 rpm, 7min, 4 ºC. 
25) Remove the supernatant. 
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26) Add HEPES / NaCl 5 ml / PMSF 12.5 µl / Leupeptin 1 µl / Pepstatin 1 µl to 
dissolve pellet again 
27) Centrifuge at 4,000 rpm, 7min, 4 ºC. 
28) Remove the supernatant. 
29) Add IP dilution buffer 200〜500 µl / PMSF 1.25 µl / Leupeptin 1 µl / Pepstatin 1 µl 
to dissolve pellet again. 
30) Add SDS Lysis buffer 200〜500 µl / PMSF 1.25 µl / Leupeptin 1 µl / Pepstatin 1 µl. 
31) Sonication for 12 times (30sec on, 30sec off, repeat 12 times). 
32) Dispensed into Eppens and frozen in liquid nitrogen and stored at - 80 º C (50μl as 
the input, the rest is dispensed for IPs treatment). 
Sonication check 
1) Mix 10ul sample and 100ul IP Dilution buffer and incubate at 65 ºC overnight. 
2) Add 100 µl Phenol-chloroform and vortex. 
3) Centrifuge at 14,000 rpm, 5min, RT.  
4) Collect the supernatant. 
5) Add two times of Ethanol and keep at - 80 º C for 10 min. 
6) Centrifuge at 14,000 rpm, 5min, RT.  
7) Remove the supernatant. 
8) Vacuum Dry. 
9) Add 20 µl TE + RNase and incubate at 37º C for 30 min. 
10) Electrophoresis check. 
 
Day 2 
Equilibration of beads (operate on ice). 
1) Add beads 20 µl /30 µl to each eppen. 
2) Add 250 µl Protein A/G. 
3) Centrifuge at 3,000 rpm, 1min, 4 ºC. 
4) Remove the supernatant. 
5) Repeat from 1) to 4) again. 
IPs 
1) Dissolve samples on ice. 
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2) Add IP Dilution buffer until SDS concentration decrease to less than 1% / PMSF 2.5 
µl / Leupeptin 1 µl / Pepstatin 1 µl. 
3) Centrifuge at 14,000 rpm, 5min, 4 ºC. 
4) Collect the supernatant and transfer to 20 µl equilibrated beads. 
5) Rotation for 30 min, 4 ºC. 
6) Centrifuge at 3,000 rpm, 1min, 4 ºC. 
7) Collect the supernatant and transfer to 30 µl equilibrated beads. 
8) Add 2 µl Flag antibody (without HRP). 
9) Rotate at 4 ºC for more than 6 hours.
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Day 3 
WASH IPs 
1) Centrifuge at 3,000 rpm, 1min, RT. 
2) Add 950 µl TSE-150. 
3) Rotate 3min. 
4) Centrifuge at 3,000 rpm, 30sec, RT. Remove the supernatant. 
5) Add 950 µl TSE-500. 
6) Rotate 3min. 
7) Centrifuge at 3,000 rpm, 30sec, RT. Remove the supernatant. 
8) Add 950 µl LiCl / Detrgent Wash (LiDW). 
9) Rotate 3min. 
10) Centrifuge at 3,000 rpm, 30sec, RT.  
11) Remove the supernatant. 
12) Add 950 µl TE. 
13) Rotate 3min. 
14) Centrifuge at 3,000 rpm, 30sec, RT. Remove the supernatant. 
15) Add 600 µl TE, transfer the beads to new eppen. 
16) Rotate 3min. 
17) Centrifuge at 3,000 rpm, 30sec, RT. Remove the supernatant. 
18) Add 250 µl SDS / NaHCO3. 
19) Rotate 15min. 
20) Centrifuge at 3,000 rpm, 30sec, RT. Collect the supernatant to new eppen*. 
21) Repeat 18) to 20), Collect the supernatant to the same eppen* as marked in 20).  
22) Add 20 µl 5 M NaCl. 
23) Vortex. 
24) Incubate at 65 ºC for 4 ~6 hours. 
Proteinase K Treatment 
1) Add twice the volume of 100% Ethanol. 
2) Keep 15min at -80ºC, or, keep overnight at -20ºC. 
3) Centrifuge at 14,000 rpm, 10min, 4 ºC. Remove the supernatant. 
4) Add 100 µl 70% Ethanol. 
5) Centrifuge at 14,000 rpm, 10min, 4 ºC. 
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6) Remove the supernatant. Dry. 
7) Add 100 µl TE. 
8) Mix by pipetman. 
9) Add 25 µl 5×Protein K buffer. 
10) Add 1.5 µl Proteinase K (20 mg/ml). 
11) Incubate at 42 ºC for 1-2 hours. 
12) Add 175 µl TE to Flag sample and 275 µl to total.  
13) Add the same volume Phenol/Chloroform. 
14) Vortex. 
15) Centrifuge at 14,000 rpm, 5min, RT. Collect the supernatant. 
16). Add the same volume Chloroform. 
17) Vortex. 
18) Centrifuge at 14,000 rpm, 5min, RT. Collect the supernatant. 
19) Add 1 µl Glycogen (20 mg/ml). 
20) Add 1/10 of sup volume 3 M NaOAc. 
21) Add twice the volume of 100% Ethanol. 
22) Keep overnight at -20 ºC. 
Day 4  
1) Centrifuge at 14,000 rpm, 15min, 4 ºC. 
2) Remove the supernatant. 
3).Add 100 µl 70% Ethanol. 
4) Centrifuge at 14,000 rpm, 5min, 4 ºC. 
5) Remove the supernatant. Dry. 
6) Add 100 µl TE buffer to total and 20 µl to sir sample. 
7) Add 1 µl RNase (1 µg/µl). 
8) Incubate at 42 ºC, 1 hour. 
9) Keep at -20ºC 
Day 5  
Check DNA concentration and then carry out RT-PCR 
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Immunoprecipitation assay  
1) Grow yeast into YPD medium to an OD600=2.0 and harvest cells (2.0 X 10
7
 cells/ml) 
X 300 ml with repeated centrifugation 
2) Wash cells with 1xPBS buffer and cell pellets are freezed in liquid nitrogen and make 
powder with beat beater.  
3) Suspend the cell powder in 0.8 ml of lysis buffer [50 mM HEPES-KOH at pH 7.5, 
300 mM KCl, 0.05% Tween-20, 0.005% NP-40, 10% glycerol, 0.2 μg/ml Pepstain A, 
0.2 μg/ml Leupeptin, 1 mM PMSF, 2 mM β-glycerophosphate, 2 mM NaF, 0.4 mM 
Na3VO4, 0.5 mM Na-pyrophosphate] containing 5 mg/ml bovine serum albumin 
(BSA). 
4) Cell lysates were cleared by centrifugation for 20 min at 4ºC and repeat this step.  
5) Protein extracts were adsorbed onto 0.5 ml of sepharose 4B Fast Flow (GE 
Healthcare) for 1h rotation at 4ºC.  
6) The beads were then pelleted, and the supernatant was recovered and mixed with 50 
μl anti-Flag-agarose (M2) beads (Sigma) for 3hrs continuous rotation at 4ºC.  
7) The beads were washed six times with lysis buffer containing 0.1 mg/ml BSA, then 
washed three times with 1 ml cold lysis buffer.  
8) The immunocomplex was eluted by incubating the beads with lysis buffer containing 
100 μg/ml 3xFlag peptides (Sigma).  
9) Then proteins are separated following SDS-PAGE and visualize by the 
SilverQuestTM Silver Staining Kit (Invitrogen).  
* Elution buffer 
Lysis buffer 100 µl 
5mg/ml 3×Flag peptide 2 µl 
 
Silver staining by SilverQuestTM Kit.  
1) After electrophoresis, remove the gel from the cassete and place the gel into a clean 
box.  
2) Rinse the gel briefly with ultrapure water. Then add 50 ml of fixative and shake for 
20 minutes.  
3) Decant the fixative solution and wash the gel in 30% ethanol for 10 minutes.  
4) Decant the ethanol and add 50 ml of Sensitizing solution and incubate for 10 
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minutes.  
5) Decant the Sensitizing solution and wash the gel in 50 ml of 30% ethanol for 10 
minutes.  
6) Wash the gel in 50 ml of ultrapure water for 10 minutes. Then add 50 ml of 
Staining solution and incubate for 15 minutes.  
7) After staining is completed, decant the Staining solution and wash the gel with 50 
ml of ultrapure water for 20-60 seconds.  
8) Add 50 ml of Developing solution and incubate for 4-8 minutes until bands start to 
appear clearly.  
9) Add 5 ml of Stopper and agitate the gel for 10 minutes.  
10) The color changes from pink to colorless indicating that the development has 
stopped. Decant the Stopper solution and wash the gel with 50 ml of ultrapure 
water for 10 minutes.  
11) Visualize the protein bands. 
 
Immunobloting Assay 
Prepare sample for Immunobloting Assay 
1) Grow yeast into 5 ml YPD medium to an OD600=2 
2) Centrifuge at 6000 rpm for 3 min at 4ºC 
3) Collect cells and washed with 1 ml of cold 1xPBS 
4) Centrifuge at 6000 rpm for1 min at 4ºC 
5) After centrifuge remove 1xPBS 
6) Then add 50µl 3xSDS sample buffer to the cell 
7) Incubate 3 min at 95ºC 
SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
1) Clean the glass plate by Ethanol. 
2) Assemble the glass plate. 
3) Prepare lower gel (Gel% depends on protein size) 
4) Pour lower gel into a glass cassete around 10 cm. 
5) Add 1 ml distilled water on the lower gel 
6) Remove water after 15 min when lower will be solid 
7) Make upper gel 
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8) Pour the upper gel on the lower gel and insert the comb within the gel. 
9) Remove the comb after 15 mins and place the gel within electrophoresis apparatus. 
10) Add running buffer. 
11) Apply the sample. 
12) Run the samples at 10 mA for 10 min →20 mA for 60 min. 
 
Western Blotting. 
To transfer protein band from gel to PVDF membrane we need three pieces of sponges, 
two pieces of chromatographic papers and 1 piece of PVDF membrane 
1) The PVDF membrane was immersed in methanol, rinsed well with distilled water, 
and then immersed in transfer buffer within the tray. 
2) Transfer chromatographic papers and sponges in transfer buffer within the tray and 
keep 10-15 minutes 
3) Remove the gel from the glass cassete and transfer gel in transfer buffer within the 
tray.  
4) Add transfer buffer into the electronic apparatus and place ice to the electronic 
apparatus. 
5) Before transfer PVDF membrane together with chromatographic papers and sponges 
to the transfer buffer following order should be maintained and insert everything 
into a special plastic tray, close the tray and make a cassette. 
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6) Then transfer the plastic cassette (PVDF membrane together with chromatographic 
papers and sponges) to the transfer buffer within the electronic apparatus. 
7) Run at 400 mA for 1 hr  
8) Remove the membrane from the cassete, immersed in amio black 10 sec. 
9) Rinse several times with distilled water. 
10) Scan the membrane. 
11) Prepare 5% skin milk (diluted with TBS-T) to incubate the PVDF membrane 
12) Incubate the membrane within skin milk for 30 mins to overnight (shaking at room 
temperature) 
13) Add antibody to the membrane (diluted 1000-fold to 2000) . 
14) Incubate for 1h. 
15) Wash by TBS-T 3 times (shaking for 30 mins at room temperature) 
16) Add 200 µl Solution A and 200µl Solution B (Immunochemical reagent). 
17) Take picture. 
＊Reagents for making gel 
30% polyacrylamide 
Distilled water 
Buffer 
 10% APS 
TEMED 
＊Tansfer buffer 
Tris Base               9.1 g 
Glycine                43.2 g 
Methanol                 600 ml 
10% SDS                 30ml 
up to H2O                  2 L 
＊Transfer buffer 
5×TG                   600 ml 
MeOH                  600 ml 
SDS                       3 g 
up to H2O                  2 L 
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＊TBS-T 
1 M Tris（pH7.9）             20 ml 
5 M NaCl                     60 ml 
Tween 20                      1 ml 
up to H2O                      2L 
*Amido Black 
15% Amido Black 
*blocking solution 
5% skin milk 
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